https://rjrindex.com/articles/revisiting-accessible-therapies-for-the-management-of-myelodysplastic-syndromes-a-retrospective-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/life-years-and-quality-adjusted-life-years-with-belantamab-mafodotin-bortezomib-and-dexamethasone 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differences-in-outcomes-with-intensive-chemotherapy-in-aml-patients-according-to-mutational-status 2026-08-17 monthly 0.7 https://rjrindex.com/articles/altered-bone-marrow-bm-plasma-amino-acid-aa-composition-reflects-microenvironmental-remodeling-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/piezo1-mediated-mechanosensation-in-bone-marrow-macrophages-promotes-hematopoietic-support-function 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-clinical-experience-with-mesenchymal-stromal-cells-in-autoimmune-hemolytic-anemia-a-cas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-with-acalabrutinib-in-ighv-mutated-setting-and-presence-of-splenomegaly-are-the-main-predi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-profiling-reveals-mdsc-driven-immunosuppressive-remodeling-of-the-tumor-microenvironment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-and-non-overlapping-epigenetic-signatures-differentiate-mpn-subtypes-and-reveal-hydroxyurea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lisocabtagene-maraleucel-liso-cel-demonstrates-superior-efficacy-across-inflammatory-risk-subgroup 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-mantle-cell-lymphoma-in-colombia-a-multicenter-cohort-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-mediastinal-b-cell-lymphoma-survival-trends-and-statistics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-teclistamab-in-relapsed-or-refractory-multiple-myeloma-results-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dysregulated-proteasome-proteostasis-acts-as-a-driver-of-light-chain-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-the-treatment-of-secondary-central-nervous-system-lymphoma-scnsl-with-intensive-systemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-the-biological-function-foxo3-and-its-role-as-a-predictive-biomarker-in-htlv-1-relate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glucose-transporter-5-enhances-car-t-cell-metabolic-function-and-serial-killing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-thromboprophylaxis-use-during-autologous-hematopoietic-stem-cell-transplantat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-car-t-cell-therapy-in-chronic-lymphocytic-leukemia-a-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-first-and-second-generation-flt3-inhibitors-in-newly-diagnosed-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/demystifying-changes-with-upfront-therapy-in-mantle-cell-lymphoma-global-clinician-preparedness-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/apcin-derived-cdc20-inhibitors-synergize-with-microtubule-disruptors-to-induce-mitotic-catastrophe-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-postnatal-loss-of-mature-osteoblasts-creates-an-immunosuppressive-bone-marrow-microenvironme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reprogrammed-regulatory-t-cells-as-cytotoxic-effectors-drive-anti-tumor-immunity-under-bispecific-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ddx3x-facilitates-adaption-to-proteotoxic-stress-by-regulating-the-translation-of-mapkapk2-and-the-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-dose-10-day-decitabine-plus-venetoclax-induced-rapid-mrd-negativity-and-durable-remission-in-de 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-vulnerability-and-mortality-trends-in-acute-myeloid-leukemia-in-the-united-states-adults-201 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-treatment-immune-profiling-by-flow-cytometry-and-single-cell-transcriptomics-identifies-distinct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-investigation-of-somatic-mutations-in-idh-genes-in-peripheral-blood-in-the-all-of-us-research-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-dependent-long-short-term-memory-neural-cox-regression-in-2690-patients-with-myeloid-neoplasia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-of-acute-myeloid-leukemia-with-isocitrate-dehydrogenase-1-idh1-mutation-treated-with-combin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heterogeneous-clinical-outcomes-within-contemporary-risk-strata-a-genomic-reappraisal-of-2022-eln-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improvements-in-mental-health-symptoms-are-associated-with-improved-quality-of-life-over-time-in-adu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-derived-secondary-car-t-cell-therapy-for-relapsed-leukemia-following-initial-car-t-bridged-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-autologous-cd30car-t-cells-in-combination-with-nivolumab-in-patients-with-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bridging-the-rural-gap-real-world-teclistamab-outcomes-from-the-us-midwest-myeloma-network 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-multiple-myeloma-mortality-in-the-united-states-a-25-year-analysis-from-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-cd371-shielded-hematopoietic-stem-cell-grafts-for-protection-against-aml-directed-imm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tracking-clonal-dynamics-tolerance-and-adverse-events-after-cd45-adc-conditioned-autologous-hspc-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-multi-center-review-of-the-safety-and-efficacy-of-bispecific-t-cell-engagers-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-crisis-to-cure-thirteen-years-of-real-world-trends-in-acute-promyelocytic-leukemia-outcomes-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasmacytoid-dendritic-cell-associated-acute-myeloid-leukemia-pdc-aml-a-comprehensive-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-iii-study-to-investigate-the-combination-of-lp-118-ponatinib-vincristi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-proteomic-signature-derived-by-ensemble-machine-learning-for-predicting-relapse-in-pediatric-b-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crosstalk-between-cep72-germline-polymorphism-and-notch1-somatic-mutations-alters-the-sensitivity-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-prophylaxis-with-11-ratio-pdvwffviii-concentrate-vs-recombinant-vwf-in-ty 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-transposon-baff-ligand-directed-chimeric-antigen-receptor-t-cells-lmy-920 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-patients-at-risk-of-prolonged-neutropenia-and-enhanced-risk-of-complications-during-aza 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-cancer-related-mortality-in-hematological-cancers-a-nation-wide-population-based-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-polatuzumab-vedotin-plus-rituximab-cyclophosphamide-doxorubicin-and-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-lung-function-results-for-sleep-disordered-breathing-in-children-with-sickle-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-one-month-mortality-and-bleeding-outcomes-with-caplacizumab-in-thrombotic-thrombocytopeni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vitro-and-in-vivo-foxo3-dependent-induction-of-fetal-hemoglobin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolomic-and-epigenetic-signatures-of-hemin-induced-stress-in-sickle-cell-erythroblasts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-obinutuzumab-plus-chlorambucil-in-treatment-naive-chronic-lymphocytic-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vsa012-a-cfb-targeted-sirna-demonstrates-a-favorable-safety-profile-and-sustained-efficacy-in-pnh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/restarting-etentamig-therapy-after-dosing-delays-or-interruptions-population-pharmacokinetics-popp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-circulating-cd57-cytotoxic-cell-subsets-across-disease-stage-and-aggressiveness-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/more-than-a-bulk-higher-incidence-of-venous-thromboembolism-vte-in-patients-with-primary-mediasti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extended-treatment-free-hospitalization-free-time-and-quality-of-life-benefits-with-car-t-cell-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-importance-of-mri-in-diagnostic-workup-of-smoldering-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-practices-in-the-management-of-pediatric-iliofemoral-deep-vein-thrombosis-results-of-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upregulation-of-bcma-expression-by-selinexor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pattern-of-infections-and-impact-on-immunocompetence-of-next-generation-b-cell-depleting-immunothera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/large-b-cell-lymphoma-after-cd19-car-t-failure-updated-real-world-outcomes-prognostic-factors-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-aponermin-kt-decp-in-patientspts-with-relapsedrefractory-multiple-myeloma-and-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rock2-inhibition-attenuates-ctl-mediated-platelet-destruction-by-suppressing-il-6stat3-driven-glyco 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-implementation-of-bispecific-antibody-delivery-in-community-oncology-overcoming-operatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eo2463-eo-peptide-immunotherapy-in-patients-pts-with-newly-diagnosed-asymptomatic-follicular-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cyclin-d1-immunostaining-as-a-diagnostic-surrogate-for-the-t1114-translocation-in-al-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-response-and-toxicity-profiles-of-sequential-bispecific-antibody-therapies-in-relapsedre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/is-dual-targeting-of-fxii-and-gas6-a-good-strategy-to-prevent-thrombosis-with-no-risks-of-bleeding 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-preclinical-study-on-the-synergy-between-cd73-inhibitors-and-selinexor-for-managing-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mecapegfilgrastim-for-prophylaxis-of-immunochemotherapy-induced-neutropenia-in-patients-with-diffuse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tocilizumab-prophylaxis-in-patients-receiving-car-t-cell-immunotherapy-for-hematological-malignancie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-open-label-rollover-study-to-assess-the-long-term-safety-of-ixazomib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hiv-1-infected-scd-patients-exhibit-milder-sickle-cell-disease-and-suppressed-antiviral-innate-immun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-89zr-dfo-daratumumab-for-cd38-targeted-imaging-of-multiple-myeloma-the-immunopet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-with-concomitant-chronic-lymphocytic-leukemia-common-or-distinct-clonal-origin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pozelimab-plus-cemdisiran-versus-ravulizumab-in-patients-with-paroxysmal-noct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/psychosocial-well-being-in-patients-undergoing-allogeneic-hematopoietic-stem-cell-transplantation-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/innate-immune-dysregulation-in-monocytes-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-red-blood-cell-functional-biomarkers-following-hematopoietic-cell-transplantation-in-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-mortality-associated-conditions-hospitalizations-and-costsrelated-to-hemophago 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-additional-genetic-variants-in-the-course-of-erdheim-chester-disease-and-their-evolution-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hereditary-alpha-tryptasemia-hat-extends-the-symptom-spectrum-to-cardiovascular-pain-and-neuropsy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelets-enhance-factor-viii-activity-through-protection-from-activated-protein-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-therapy-related-acute-lymphoblastic-leukemia-a-population-based-analysis-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-dose-inotuzumab-ozogamicin-combined-with-vincristine-and-prednisone-regimen-as-induction-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/induction-mortality-in-acute-leukemia-the-hidden-burden-of-infections-in-a-middle-income-country 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-biological-impact-of-plasma-cytokine-levels-in-newly-diagnosed-chronic-lymphocytic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-disparities-in-sickle-cell-disease-among-patients-with-asymptomatic-hiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/persistent-symptom-burden-and-unmet-needs-in-long-term-survivors-of-allogeneic-hematopoietic-cell-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-large-language-model-based-framework-for-automated-phenotypic-characterization-in-myeloproliferati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-npm1-co-mutation-on-outcomes-in-ras-mutated-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mesenchymal-stem-cells-for-treating-gastrointestinal-involved-steroid-refractory-acute-graft-versus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-ciltacabtagene-autoleucel-cilta-cel-versus-belantamab-mafodotin-belamaf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-cyclophosphamide-based-graft-verses-host-disease-gvhd-prophylaxis-is-associated-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-genomic-analysis-of-patients-with-chronic-lymphocytic-leukemia-treated-with-fixed-duration-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-rubricbased-comparison-of-code-red-and-specialists-in-managing-cart-related-cytokine-release-syn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/psychometric-evaluation-of-the-self-management-skills-checklist-across-brazil-and-the-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/craniofacial-involvement-is-associated-with-poor-prognosis-in-extranodal-dlbcl-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-mitapivat-treatment-improves-inflammatory-pro-fibrotic-cardiomyopathy-in-a-murine-model-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-molecular-heterogeneity-and-clonal-evolution-in-chronic-myelomonocytic-leukemia-via-single 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-stratification-of-relapse-risk-post-allogeneic-hematopoietic-stem-cell-transplantation-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-rates-of-deep-molecular-response-dmr-in-patients-pts-with-chronic-myeloid-leukemia-in-chron 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-engaging-bispecific-antibody-shows-potent-mrd-negativity-with-variable-remission-and-survival 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-iron-deficiency-anemia-on-outcomes-in-postpartum-hemorrhage-insights-from-a-national-inpa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/6ploh-as-a-marker-of-immune-mediated-bone-marrow-failure-insights-from-a-large-single-center-experi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-immune-profiles-among-patients-with-primary-effusion-lymphoma-and-other-kaposi-sarcoma-herp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-prognostic-significance-of-myelodysplastic-syndrome-mds-related-features-in-ve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-in-cll-patients-after-btk-inhibitor-progression-identifies-enrichment-of-mutations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-the-international-working-group-iwg-2023-criteria-for-clinical-benefit-in-higher-ris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-multiproteomic-analysis-reveals-an-inflammatory-phenotype-in-immune-aplastic-anemia-ch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-of-whole-genome-sequencing-for-genomic-profiling-and-risk-determination-in-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-evaluation-of-the-relationship-between-abnormal-myocardial-perfusion-and-diastolic-dysfunction-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effects-of-bruton-tyrosine-kinase-inhibitors-on-the-waldenstrom-macroglobulinemia-microenvironme 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-histopathological-subtyping-of-peripheral-t-cell-lymphoma-ptcl-on-hampe-stai 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-predictors-of-cardiovascular-disease-risk-in-mds-patients-results-of-a-pros 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-trial-of-siltuximab-in-combination-with-standard-induction-chemotherapy-in-patients-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pegylated-interferon-alfa-2b-combined-with-tyrosine-kinase-inhibitors-in-chro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genome-wide-crispr-cas9-screening-identified-gpcr-regulators-ric8a-and-pdcl-as-therapeutic-targets-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcome-of-nodal-t-cell-non-hodgkin-lymphoma-from-hematology-cancer-consortium-registry-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplant-results-in-t-cell-prolymphocytic-leukemia-t-pll-a-collaborative-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/total-metabolic-tumor-volume-as-a-prognostic-biomarker-in-high-burden-follicular-lymphoma-a-systema 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-driven-prognostication-of-overall-survival-at-6-months-after-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-thrombopoietin-receptor-agonists-for-thrombocytopenia-in-pediatric-malignancies-a-retrospect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/avatrombopag-beyond-the-technical-sheet-a-single-center-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-voxelotor-treatment-in-patients-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/favorable-safety-and-therapeutic-efficacy-of-a-novel-humanized-anti-adamts13-antibody-in-acquired-vo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-fcrn-inhibitors-versus-placebo-in-adult-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-combined-with-anti-cd19-car-t-cell-therapy-in-relapsed-and-refractory-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upfront-maintenance-therapy-improves-the-prognosis-of-patients-with-diffuse-large-b-cell-lymphoma-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/consolidation-of-adult-inpatient-sickle-cell-care-to-improve-patients-and-learners-experiences-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-immunotherapy-in-alveolar-soft-part-sarcoma-asps-a-case-report 2026-08-17 monthly 0.7 https://rjrindex.com/articles/js203-a-cd20cd3-bispecific-antibody-demonstrated-promising-anti-cancer-activity-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifi16-drives-bortezomib-resistance-in-multiple-myeloma-via-wntv-catenin-pathway-a-novel-therapeuti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/establishment-of-a-prognostic-model-for-diffuse-large-b-cell-lymphoma-based-on-mitochondrial-energy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-of-composite-lymphoma-and-multiple-cancer-diagnoses-in-an-individual-heterozygous-for-fanci-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-survival-analysis-at-a-large-united-states-southern-comprehensive-sickle-cell-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-gender-and-geographic-disparities-in-leukemia-clinical-trials-authorship 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-for-black-persons-with-multiple-myeloma-a-national-retrospective-trend-analysis-from-2015 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zuma-25-preliminary-analysis-a-phase-2-study-of-brexucabtagene-autoleucel-brexu-cel-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-risk-based-scoring-approach-to-individualize-prophylaxis-in-patients-with-hemophilia-a-results-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bms-986458-a-first-in-class-highly-selective-and-potent-ligand-directed-degrader-ldd-of-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-fatigue-on-health-care-resource-utilization-and-costs-in-sickle-cell-disease-in-the-united 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-concentrations-in-cerebrospinal-fluid-in-patients-with-hemophagocytic-lymphohistiocytosi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idiopathic-multicentric-castleman-disease-unresponsive-to-one-il-6-inhibitor-may-respond-to-another 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decoding-neurotoxicity-a-multi-disease-single-cell-atlas-of-cerebrospinal-fluid-reveals-conserved-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-psychosocial-impact-of-myelodysplastic-syndromes-evaluation-by-self-report 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-with-eliglustat-for-gaucher-disease-type-1-in-china-a-multicenter-retrospective 2026-08-17 monthly 0.7 https://rjrindex.com/articles/standardizing-lines-of-treatment-lot-in-multiple-myeloma-real-world-validation-of-an-automated-ru 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-a-clinical-trial-communication-training-workshop-on-hematology-oncology-fellows-knowl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/county-level-analysis-reveals-two-high-incidence-regions-and-potential-environmental-contributors-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hetrombopag-for-the-treatment-of-lower-risk-myelodysplastic-syndromes-with-thrombocytopenia-a-prosp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-stratified-prognostic-performance-of-patient-vs-disease-related-ipi-factors-in-large-b-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-high-dose-methotrexate-addition-to-r-chop-chemotherapy-for-prophylaxis-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloproliferative-neoplasms-in-mexico-an-analysis-of-clinical-features-driver-mutations-and-dise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rising-burden-of-hemophagocytic-lymphohistiocytosis-in-the-united-states-a-nationwide-analysis-of-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-associated-non-mutational-resistance-in-acute-myeloid-leukemia-is-driven-by-dna-damage-induced-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-in-frame-calreticulin-mutation-induces-activation-of-jak-stat-signaling-and-thrombocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/administration-and-adverse-event-related-costs-among-patients-with-multiple-myeloma-treated-with-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-safety-and-efficacy-of-belumosudil-and-ruxolitinib-combination-in-ruxolitinib-refractory-chronic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-gene-panel-analysis-in-aplastic-anaemia-diagnostic-utility-and-clinical-implications 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-data-from-the-non-transfusion-dependent-dose-confirmation-cohort-a-phase-2a-study-of-luspate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pregnancy-outcomes-in-hereditary-and-transfusion-associated-hemochromatosis-a-focused-propensity-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/navigating-triple-therapy-in-a-high-risk-cardiac-patient-with-a-covered-stent-and-embolic-stroke-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/n6-methyladenosine-m6a-rna-modification-is-required-to-final-plasma-cell-differentiation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-dynamics-and-clinical-outcomes-in-patients-with-heparin-induced-thrombocytopenia-single-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heparin-induced-thrombocytopenia-after-percutaneous-coronary-intervention-complicated-by-hemothorax 2026-08-17 monthly 0.7 https://rjrindex.com/articles/automated-ai-classification-in-clinical-flow-cytometry-transforming-b-cell-lymphoma-diagnostics 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-39il-39r-signaling-drives-acute-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relapse-associated-aberrant-dna-hypermethylation-in-aml-post-allogeneic-stem-cell-transplantation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-reprogramming-by-itaconate-haescs-derived-therapy-targets-fibroblast-glud1-to-alleviate-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-satisfaction-with-outpatient-management-of-sickle-cell-pain-crisis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-july-effect-on-sickle-cell-crisis-hospitalizations-a-national-inpatient-sample-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/accelerate-a-platform-protocol-to-investigate-post-transplant-cyclophosphamide-based-graft-versus-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-read-profiling-of-structural-variants-reveals-mechanisms-of-chemo-resistance-and-prognostic-het 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bms-986458-a-first-in-class-bifunctional-cereblon-dependent-ligand-directed-degrader-of-b-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrutinib-enhances-41bb-costimulated-cart19-function-and-persistence-through-immune-reprogramming-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luspatercept-reduces-cardiac-stress-and-improves-cardiac-function-in-a-tet2-deficient-mouse-model-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/triple-base-edited-dual-targeting-cd7033-car-t-cells-to-avoid-cytokine-mediated-resistance-in-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zilovertamab-vedotin-plus-r-chp-versus-polatuzumab-vedotin-plus-r-chp-as-first-line-therapy-in-parti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orca-t-demonstrates-favorable-quality-of-life-and-healthcare-resource-use-compared-to-standard-alloh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frieds-frailty-phenotype-predicts-survival-in-pts-with-relapsedrefractory-lymphoma-or-myeloma-unde 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dars-mediated-m2-polarization-of-tumor-associated-macrophages-drives-mpn-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-death-and-comorbidities-in-v-thalassemia-carriers-identified-by-consecutive-genotyping-a-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-asc-in-chronic-myeloid-leukemia-in-chronic-phase-cml-cp-interim-analysis-ia-efficac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-cmv-reactivation-in-multiple-myeloma-patients-receiving-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-in-patients-with-newly-diagnosed-acute-myeloid-leukemia-with-kmt2a-rearrangement-treated-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/accelerating-access-to-gene-therapy-lessons-from-commercial-implementation-in-sickle-cell-disease-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-center-retrospective-evaluation-of-chop-based-regimens-in-older-patients-with-treatment-naive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lung-infections-and-clinical-outcomes-of-diffuse-large-b-cell-lymphoma-treated-with-polatuzumab-vedo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trium-study-exploring-mrd-guided-triplet-therapy-with-sonrotoclax-zanubrutinib-and-cd20mab-in-unt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-car-t-cell-therapy-using-a-multimodal-approach-to-target-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-epcoritamab-monotherapy-induces-high-response-and-mrd-negativity-rates-in-elderly-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiovascular-adverse-events-associated-with-bispecific-antibodies-in-relapsedrefractory-hematolog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/imv101-a-novel-cd19-targeted-in-vivo-car-t-therapy-exhibits-potent-efficacy-and-tolerable-safety-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd19-antigen-from-tumor-target-to-safety-switch-able-to-improve-the-safety-profile-of-car-t-cell-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-treatment-cd19-antigen-density-and-multi-antigen-profiling-by-calibrated-quantitative-flow-cytom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-analyses-of-molecular-tumor-burden-are-superior-to-pet-assessed-responses-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spliceosome-mutations-in-aml-prevalence-clinical-features-and-treatment-outcomes-in-a-contemporar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-azd0120-a-bcmacd19-dual-targeting-car-t-cell-therapy-in-relapsedrefractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etentamig-plus-pomalidomide-dexamethasone-combination-therapy-in-relapsed-or-refractory-multiple-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prophylactic-tocilizumab-in-relapsedrefractory-multiple-myeloma-patients-treated-with-bispecific-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-transcriptomic-signatures-in-non-hispanic-black-aml-patients-with-npm1-mutations-reveal-pot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allograft-inflammatory-factor-1-is-essential-for-acute-monocytic-leukemia-infiltration 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-the-safety-of-ciltacabtagene-autoleucel-in-relapsed-multiple-myeloma-mm-identification 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mim8-prophylaxis-in-adults-and-adolescents-with-hemophilia-a-52-week-efficacy-and-safety-outcomes-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-outcomes-by-line-of-therapy-in-marginal-zone-lymphoma-real-world-evidence-from-10-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/choice-of-hypomethylating-agent-for-newly-diagnosed-tp53-mutant-acute-myeloid-leukemia-a-command-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/double-hit-alterations-of-tp53-identify-ultra-high-risk-disease-in-previously-treated-myd88-mutated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-limited-pirtobrutinib-venetoclax-and-obinutuzumab-combination-in-first-line-chronic-lymphocyt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/odronextamab-plus-chemotherapy-in-patients-with-previously-untreated-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-gilteritinib-beyond-second-line-therapy-in-relapsedrefractory-flt3-muta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/macrophage-subsets-provide-distinct-niches-for-normal-and-clonal-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd44v6-promotes-anti-apoptotic-phenotypes-in-aml-via-an-spp1-mediated-autocrine-activation-of-the-ma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il18-armored-car-t-cells-in-relapsedrefractory-b-cell-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/embedding-narrative-medicine-into-subspecialty-training-a-novel-clinical-rotation-to-foster-humanis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tdi01-in-the-treatment-of-moderate-to-severe-chronic-graft-versus-host-disease-updated-results-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-autologous-hematopoietic-stem-cell-transplantation-in-nodular-lymphocyte-predominant-hod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subsequent-primary-malignancies-after-car-t-therapy-a-study-from-the-us-multiple-myeloma-immunother 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-dna-profiling-unveils-clonal-evolution-and-identifies-mechanisms-of-therapeutic-resistan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/randomized-comparison-of-ponatinib-versus-imatinib-in-combination-with-chemotherapy-in-patients-55-y 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-breakthrough-hemolysis-on-complement-factor-h-and-factor-i-levels-in-paroxysmal-noctur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-of-co-mutation-of-sf3b1-and-bcrabl1-demonstrating-an-mds-phenotype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-viral-pneumonia-on-hospital-outcomes-in-sickle-cell-disease-a-database-review-and-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-cns-ipi-score-is-predictive-of-severe-immune-effector-cell-associated-neurotoxicity-after-axicab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-diagnosis-of-iron-deficiency-among-patients-receiving-a-blood-transfusion-in-the-emerg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trust-and-relationships-between-people-with-sickle-cell-disease-and-healthcare-professionals-region 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hla-b-leader-matching-status-on-prognosis-and-underlying-mechanism-in-patients-with-hemato 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implementing-patient-centered-proms-in-sickle-cell-disease-care-a-european-consensus-approach 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-initial-flt3-itd-mutated-clone-numbers-on-clinical-outcomes-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-and-sepsis-related-mortality-in-the-united-states-us-older-adults-nation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-development-of-ft839-an-off-the-shelf-cd19xcd38-dual-car-t-cell-for-the-treatment-of-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/late-recurrence-of-transfusion-dependent-thalassemia-30-years-after-transplantation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/calcineurin-inhibitors-reduce-risk-of-mgus-progression-to-multiple-myeloma-in-immunosuppressant-user 2026-08-17 monthly 0.7 https://rjrindex.com/articles/specific-environmental-factors-are-associated-with-increased-rates-of-invasive-mucormycosis-infectio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adverse-genetic-alterations-and-their-prognostic-impact-in-chinese-b-all-patients-with-dux4-rearrang 2026-08-17 monthly 0.7 https://rjrindex.com/articles/brentuximab-vedotin-bvavd-efficacy-is-influenced-by-interim-pet-age-ecog-performance-status-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-diagnostic-accuracy-of-dermpathgpt01-for-dermatologic-diagnosis-in-post-allogeneic-stem-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-ai-tools-on-diagnostics-and-management-of-hematologic-malignancies-2020-20 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-abatacept-addition-to-post-transplant-cyclophosphamide-based-gvhd-prophylaxys-in-allogene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-dose-anakinra-to-treat-refractory-immune-effector-cell-associated-neurotoxicity-syndrome-in-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-nicotinamide-salvage-pathway-is-a-unique-metabolic-vulnerability-of-high-risk-mds-stem-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/volume-and-nature-of-classical-hematology-outpatient-consults-within-a-national-cancer-institute-des 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-educational-and-resource-needs-of-general-internal-medicine-physicians-in-sickle-cell-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kpg-818-a-novel-cereblon-crbn-modulator-in-patients-with-hematological-malignancies-results-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-cfdna-and-plasma-proteomics-reveal-inflammatory-heterogeneity-in-vaso-occlusive-cris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/founder-effects-and-consanguinity-shape-beta-thalassemia-genetics-a-five-year-hospital-based-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/belumosudil-in-pediatric-patients-with-steroid-refractory-chronic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficient-potent-and-specific-near-universal-base-and-prime-editing-for-elane-mutant-severe-congen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-vitamin-d-is-an-unmodifiable-adverse-prognostic-factor-in-older-dlbcl-patients-results-from-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prkra-associated-with-nf-kb-activation-in-pulmonary-involvement-of-idiopathic-multicentric-castleman 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-recognition-and-optimized-management-of-tafro-syndrome-a-10-year-experience-from-a-single-cen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-the-phase-ii-d-prism-study-daratumumab-in-high-risk-mgus-and-low-risk-smoldering-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifngh-driven-mhc-class-ii-expression-by-intestinal-epithelial-cells-dictates-local-cytolytic-th1-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-united-states-nationwide-analysis-of-sickle-cell-genotype-specific-differences-in-inpatient-outcom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-outcomes-of-non-transplanted-newly-diagnosed-multiple-myeloma-patients-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-clinical-outcomes-in-multiple-myeloma-patients-treated-with-chimeric-antigen-receptor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-efficacy-to-experience-52-week-patient-reported-outcomes-with-mim8-in-adolescents-and-adults-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hiv-status-on-clinical-outcomes-in-diffuse-large-b-cell-lymphoma-and-burkitt-lymphoma-a-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/finding-ferritin-footprints-in-5-fluorouracil-induced-cardiotoxicity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/academic-advantage-without-survival-benefit-a-national-cancer-database-analysis-of-primary-effusion 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-ruxolitinib-on-corticosteroid-treatment-patterns-in-1147-patients-with-chronic-graft-versu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ectopic-ebv-infection-in-t-cells-following-allogeneic-hematopoietic-stem-cell-transplantation-clini 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ivosidenib-combined-with-venetoclax-and-azacitidine-for-the-treatment-of-newly-diagnosed-idh1-mutant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/superior-efficacy-and-persistence-of-orca-t-allogeneic-car1922-versus-autologous-car1922-in-high-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distribution-and-risk-for-bleeding-in-patients-with-cancer-by-anticoagulant-therapy-exposure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baricitinib-reveals-lgals3bp-as-a-novel-pathogenic-factor-and-therapeutic-target-in-immune-thrombocy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-holistic-trial-a-comprehensive-evaluation-of-two-second-line-therapeutic-approaches-for-immune 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gb3226-a-novel-orally-active-first-in-class-small-molecule-inhibitor-of-enl-yeats-and-flt3-kinase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vedolizumab-for-treating-steroid-refractory-lower-gastrointestinal-acute-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-frontline-fixed-duration-chemotherapy-in-mapk-pathway-altered-adult-langerhans-cell-hist 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-b-and-t-cell-lymphomas-with-anti-cxcr5-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-co-occurring-mutations-in-npm1-mutated-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ddx41-related-myeloid-neoplasms-insights-and-treatment-landscape-in-250-patients-managed-at-a-large 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advancing-strategies-to-improve-chemotherapy-adherence-in-young-children-with-all-understanding-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-survival-and-therapy-access-in-aya-acute-lymphoblastic-leukemia-a-real-world-analysi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-of-immune-genes-rearrangements-in-chinese-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-investigator-initiated-trial-of-epcoritamab-lenalidomide-in-treatment-naive-follicular-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-based-therapies-in-patients-with-relapsedrefractory-t-cell-prolymphocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/performance-of-radiomics-features-in-patients-with-peripheral-t-cell-lymphoma-data-from-internation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-emicizumab-in-patients-with-acquired-hemophilia-a-an-interim-safety-analysis-of-a-large-scal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ai-based-secure-and-privacy-preserving-synthetic-data-generation-platform-in-transfusion-dependent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-ribosomal-readthrough-as-a-precision-medicine-strategy-for-restoring-factor-viii-expressi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilization-and-tolerability-of-r-chop-and-r-mini-chop-in-patients-with-diffuse-large-b-cell-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-pola-r-chp-in-diffuse-large-b-cell-lymphoma-a-single-center-real-world-data-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-pentamidine-for-pneumocystis-jirovecii-prophylaxis-in-allogeneic-hematopoietic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloid-sarcoma-a-population-based-retrospective-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-epitranscriptomic-biomarker-discovery-through-ensemble-analysis-and-multi-omics-integration-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flt3-testing-and-guideline-concordance-in-acute-myeloid-leukemia-across-an-indiana-health-system 2026-08-17 monthly 0.7 https://rjrindex.com/articles/practice-pattern-and-outcomes-in-dlbcl-by-genetic-subtypes-preliminary-results-from-a-large-scale-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/polatuzumab-vedotin-in-combination-with-rituximab-cyclophosphamide-doxorubicin-and-prednisone-pol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-intratumoral-cd4-t-cell-abundance-and-frequency-correlates-with-durable-clinical-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hypercoagulability-in-clonal-hematopoiesis-a-hidden-contributor-to-thrombosis-in-the-elderly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-high-dimensional-spatiotemporal-single-cell-and-3d-atlas-of-the-bone-marrow-microenvironment-durin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-time-multimodal-ai-outperforms-conventional-scores-for-early-risk-prediction-in-bcma-car-t-trea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/regional-hypometabolism-on-brain-fdg-pet-one-month-after-receiving-chimeric-antigen-receptor-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-6-and-ferritin-levels-predict-the-severity-of-cytopenia-post-car-t-cell-treatment-with-axi-cel-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-thrombocytopenic-purpura-after-allogeneic-hematopoietic-cell-transplantation-a-rare-but 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-and-cardiovascular-outcomes-among-patients-with-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/varnimcabtagene-autoleucel-in-relapsed-refractory-b-cell-malignancies-manufacturing-experience-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/generative-ai-powered-clinical-decision-support-in-germline-predisposition-to-myeloid-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/7-day-venetoclax-combined-with-intensive-chemotherapy-as-induction-treatment-in-high-risk-newly-diag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/knockdown-of-srsf10-enhances-the-sensitivity-of-aml-cells-to-cytosine-arabinoside-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-the-arhgap18pi3kakt-axis-with-vincristine-and-cytarabine-synergistically-suppresses-sene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-second-line-platinum-salvage-and-autologous-stem-cell-transplant-compared-to-cd19-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azeliragon-has-significant-activity-against-acute-myeloid-leukemia-blasts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/automated-subtype-classification-of-acute-leukemia-from-bone-marrow-smears-using-a-cross-platform-de 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-duvelisib-combined-with-chidamide-as-first-line-treatment-for-angioimmunoblas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-prevalence-of-hereditary-thrombophilia-variants-in-an-endogamous-jewish-mexican-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-elderly-patients-with-newly-diagnosed-multiple-myeloma-ndmm-a-retrospective-compariso 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-transplant-ineligible-newly-diagnosed-multiple-myeloma-patients-treated-in-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplant-following-car-t-cell-therapy-in-relapsedrefractory-adult-acute-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/performance-of-molecular-classifiers-relative-to-the-international-prognostic-index-ipi-for-overal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-plasmapheresis-on-mortality-and-length-of-stay-in-hospitalized-patients-with-thrombotic-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/torque-teno-virus-in-pediatric-car-t-recipients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-iib-randomized-clinical-trial-combining-oral-azacitidine-and-vididencel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-tqb3909a-novel-bcl-2-inhibitor-in-combination-with-azacitidine-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-outcomes-with-allo-hsct-in-nup214abl1-positive-acute-leukemia-a-pooled-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lymphodepletion-free-jl-lightning-car-t-targeting-cd19cd22bcma-achieved-100-cr-in-3-relapsedrefr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-interim-pet-in-patients-with-extranodal-natural-killert-cell-lymphoma-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-utilization-with-prophylactic-intravenous-anakinra-following-anti-cd19-car-t-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiplex-detection-of-gastrointestinal-microbiota-using-short-probes-in-graft-vs-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/concizumab-efficacy-in-patients-with-hemophilia-ab-without-inhibitors-from-the-phase-3-explorer8-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vga039-as-a-protein-s-targeted-hemostatic-promoting-monoclonal-antibody-promotes-in-vitro-thrombin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-anemia-and-hypertensive-disease-related-mortality-among-adults-aged-65-ye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-radiation-in-limited-stage-diffuse-large-b-cell-lymphoma-in-the-modern-era 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-access-and-role-of-autologous-stem-cell-transplantation-in-relapsedrefractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-mogamulizumab-trials-for-mature-t-cell-lymphomas-investigating-differences-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/switching-itp-patients-to-avatrombopag-from-other-tpo-ras-a-real-world-experience-of-the-spanish-it 2026-08-17 monthly 0.7 https://rjrindex.com/articles/imatinib-in-chronic-myeloid-leukemia-a-comparative-assessment-of-patients-in-pivotal-clinical-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-deep-dive-into-the-bone-marrow-plasma-proteome-by-optimized-extracellular-vesicle-enrichment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-therapeutic-vulnerabilities-in-flt3-mutated-aml-through-customized-crispr-screens 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-guided-optimization-of-anti-cd70-natural-ligand-based-car-lymphocytes-for-acute-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-efficacy-and-safety-of-romiplostim-n01-in-the-treatment-of-chemotherapy-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cta311-a-universal-anti-cd19-car-t-cell-therapy-with-improved-persistence-for-patients-with-cd19-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-barriers-to-treatment-access-in-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factor-analysis-of-relapse-risk-during-flt3-inhibitor-post-transplant-maintenance-therapy-follo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/underreporting-of-prognostic-factors-in-real-world-studies-for-bispecifics-in-relapsed-or-refractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-development-of-an-off-the-shelf-car-t-cell-therapy-co-targeting-cd19-and-cd38-for-broad-applicat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematologist-based-management-of-ocular-adverse-events-using-the-vra-tool-in-newly-diagnosed-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-of-patients-with-tp53-aml-treated-with-non-intensive-vidaza-venetoclax-chemotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/odyssey-a-first-in-human-study-of-the-aldehyde-dehydrogenase-aldh-inhibitor-abd-3001-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interplay-between-mutant-dnmt3a-and-uba1-worsens-survival-through-altered-inflammatory-and-metabolic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-with-third-line-car-t-therapy-vs-alternative-treatment-in-dlbcl-a-propensity-scor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-cell-dynamics-following-rituximab-and-epcoritamab-as-first-line-therapy-for-patients-with-hig 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-in-the-global-south-mapping-the-unmet-burden-using-global-burden-of-disease-dal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cre-intestinal-colonization-correlates-with-increased-progression-risk-following-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiovascular-safety-profile-of-cd20-cd3-bispecific-antibodies-compared-to-immune-checkpoint-inhi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pathogenesis-on-dysregulated-blood-glucose-homeostasis-in-severe-hand-foot-mouth-disease-mouse-model 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impacts-of-ipss-m-and-conditioning-intensity-in-allogeneic-hematopoietic-cell-transplant-for-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-late-mortality-among-allogeneic-blood-or-marrow-transplant-bmt-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-of-luspatercept-and-erythropoiesis-stimulating-agent-esa-hematological-respo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/b-cell-kinetics-on-next-generation-sequencing-after-car-t-cell-therapy-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-stem-cell-transplantation-in-pediatric-and-adolescentyoung-adult-patients-with-trisomy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-avapritinib-on-skin-lesions-in-patients-with-advanced-systemic-mastocytosis-using-a-novel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ferritin-change-and-predictors-of-anemia-response-in-ruxolitinib-intolerant-myelofibrosis-patients-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-the-bone-marrow-inflammatory-cytokine-network-in-aml-prognosis-and-immune-evasion-a-foc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/engineering-dual-specificity-ppm1d-inhibitors-to-enhance-therapeutic-response-and-overcome-chemoresi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-associated-healthcare-utilization-in-older-adults-with-aml-a-retrospective-single-center 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-mtor-and-cdk1-regulated-translation-circuits-sustain-flt3-mutated-aml-survival-under-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sociodemographic-determinants-of-survival-in-acute-lymphoblastic-leukemia-a-20-year-seer-based-anal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-canakinumab-in-patient-with-myelofibrosis-results-from-part-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/us-mortality-trends-in-acquired-aplastic-anemia-1999-2021-a-joinpoint-analysis-using-cdc-wonder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-landscape-of-extranodal-marginal-zone-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sapport-a-specialty-training-program-for-advanced-practice-providers-to-increase-knowledge-and-acce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomics-of-pediatric-b-all-bone-marrow-to-determine-mechanisms-of-durable-cd19-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/6-gingerol-ameliorates-murine-gastrointestinal-graft-versus-host-disease-by-inhibiting-pyroptosis-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacogenetic-variants-in-ugt1a1ugt1a3-and-abcc2-associate-with-deferasirox-efficacy-in-transfusi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/n-glycosylation-of-monoclonal-immunoglobulins-across-plasma-cell-dyscrasias-in-routine-care-a-cohor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improvements-in-health-related-quality-of-life-hrqol-in-the-sunmo-study-subcutaneous-sc-mosunet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-lrp1-antibody-that-identifies-upregulation-of-membrane-lrp1-on-activated-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transfusion-burden-across-hematologic-and-solid-tumors-a-real-world-comparative-study-in-aml-multi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monocytosis-as-prognostic-factor-for-chronic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-distributions-of-lymphocyte-subsets-in-myelodysplastic-syndrome-correlate-with-risk-stratif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-sequencing-bispecific-antibodies-bsab-in-patients-with-relapsed-refractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-serious-bleeding-with-concomitant-use-of-apixaban-or-rivaroxaban-with-amiodarone-compared-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tgf-v-regulates-cd123-and-chemotherapy-resistance-in-acute-myeloid-leukemia-stem-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-atrial-fibrillation-and-anemia-related-mortality-in-adults-aged-25-years 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thiopurine-pharmacogenomic-landscape-in-india-tpmt-and-nudt15-allele-frequencies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-genomic-differences-in-hispanic-vs-non-hispanic-patients-with-primary-central-nervous-system-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lessintensive-therapy-in-newly-diagnosed-acute-myeloid-leuekmia-aml-in-india-real-world-adoption 2026-08-17 monthly 0.7 https://rjrindex.com/articles/osteoblasts-differentiated-from-fviii-deficient-mice-exhibit-impaired-mineralization-capacity-and-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/durable-efficacy-of-lenzilumab-plus-azacitidine-in-newly-diagnosed-proliferative-cmml-patients-inte 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-brd4-to-reshape-the-inflammatory-microenvironment-of-senescent-bone-marrow-mesenchymal-ste 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-anti-hlh-and-antitumor-efficacy-of-golidocitinib-in-relapsedrefractory-ptcl-associated-hemopha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilisation-of-machine-learning-algorithms-to-predict-relapse-risk-following-allogeneic-stem-cell-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-autologous-hct-versus-haploidentical-donor-hct-for-ph-b-all-patients-following-tki-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-for-non-invasive-molecular-characterization-and-measurable-residual-disease-analysis-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reproductive-health-across-the-lifespan-in-acute-hepatic-porphyria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sensitive-peripheral-residual-disease-prd-detection-using-clonotypic-mass-spectrometry-easym-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rnabinding-protein-fxr1-stabilizes-receptor-tyrosine-kinase-fgfr1-and-enhances-pi3kakt-signaling-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/y-chromosome-loss-drives-sex-disparities-in-multiple-myeloma-by-reshaping-the-immune-landscape 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-meets-real-world-disparities-a-seer-based-study-of-acute-myeloid-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-patient-reported-value-of-treatment-attributes-in-follicular-lymphoma-insights-from-the-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-allogeneic-bcma-car-expressing-inkt-cells-with-pd1-deletion-demonstrate-superior-tumor-control 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-daratumumab-plus-bortezomib-lenalidomide-and-dexamethasone-d-vrd-vs-borte 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-profiling-of-pediatric-acute-myeloid-leukemia-reveals-distinct-genetic-la 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-associated-cardiotoxicity-a-systematic-review-of-case-reports-observational-studies-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discovering-the-epidemiology-treatment-patterns-and-outcomes-of-chronic-lymphocytic-leukemia-a-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selective-aso-based-jak2-inhibitor-for-the-treatment-of-hematological-malignancies-with-jak2-v617f-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-acute-pain-on-health-care-resource-utilization-and-costs-in-sickle-cell-disease-in-the-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-first-in-class-oral-clinical-candidate-targeting-mllt1-and-3-degradation-for-the-treatment-of-adva 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ml-driven-analysis-of-iscn-karyotypes-enables-detection-of-novel-prognostic-markers-in-chronic-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-allo-hct-menin-inhibition-enhances-graft-versus-leukemia-effects-by-endogenous-retrovirus-induc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unlocking-new-frontiers-in-leukemia-diagnostics-through-large-language-model-driven-report-generatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-unit-cord-blood-transplantation-reduces-the-risk-of-relapse-and-improves-leukemia-free-surviv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolic-signatures-mirror-divergent-modalities-of-leukemia-immune-evasion-and-relapse-after-transp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-experience-of-axicabtagene-ciloleucel-car-t-in-refractoryrelapsed-b-cell-lymphoma-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-center-real-world-analysis-of-treatment-outcomes-of-non-covalent-btki-pirtobrutinib-in-patie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-i-study-evaluating-the-safety-and-preliminary-efficacy-of-amulirafusp-alfa-imm0306-in-comb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-with-novel-agent-combination-therapies-for-the-frontline-treatment-of-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-invasive-classification-amp-molecular-subtyping-of-mature-lymphoid-neoplasms-by-cell-free-dna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/meteorological-impact-on-ventricular-arrhythmias-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hypoxia-driven-complement-activation-expands-circulating-endothelial-cells-in-transplant-associated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrative-surfaceome-mapping-in-aml-identifies-cd85d-as-an-immunotherapy-target 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-combined-with-decitabine-intensified-modified-busulfancyclophosphamide-conditioning-reg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/r-propranolol-promotes-lipid-synthesis-via-a-novel-non-adrenergic-pathway-to-treat-sickle-cell-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selective-germline-testing-in-multiple-myeloma-patients-yields-a-six-fold-increase-in-actionable-can 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-elranatamab-a-bcma-bispecific-antibody-for-patients-with-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ifn-gh-drives-long-term-bone-marrow-niche-dysfunction-following-chemotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-mrna-based-cytomegalovirus-vaccine-induces-robust-t-cell-immune-responses-in-cytomegalovirus-sero 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-thromboembolism-related-mortality-among-patients-with-hematologic-malignancies-in-the-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-safety-and-efficacy-in-a-phase-2-study-of-mb-105-a-cd5car-t-therapy-for-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tcr-t-cells-expressing-a-tcr-recognizing-the-mpo-propeptide-derived-mpo132-140hla-a0201-specifica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cell-therapy-related-cytokine-release-syndrome-and-neurotoxicity-real-world-outcomes-from-a-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-real-world-analysis-of-ropeginterferon-alfa-2b-use-in-patients-with-polycythemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-open-label-phase-1-study-of-a-novel-cd30-directed-antibody-drug-conjugate-with-a-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-mt-601-in-relapsed-or-refractory-rr-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-metabolic-profiling-of-post-infusion-cd22-and-cd19cd22-car-t-cells-reveals-a-shift-towa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/initial-clinical-data-from-the-phase-1-study-of-dr-01-a-non-fucosylated-anti-cd94-antibody-in-patie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/addition-of-thiotepa-to-a-busulphan-based-conditioning-regimen-does-not-improve-survival-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biallelic-tp53-aberrations-and-double-tp53-mutations-are-prevalent-in-amlmds-patients-with-del5q 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-and-cause-specific-mortality-of-aml-in-adults-from-chile 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glofitamab-based-combined-therapy-as-bridging-therapy-before-stem-cell-transplants-and-car-t-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effiefficacy-and-safety-of-allogeneic-cd123-car-nk-cell-therapy-in-relapsedrefractory-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mo-trans-update-a-randomized-double-blind-placebo-controlled-multi-center-phase-iii-study-of-moc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-epcoritamab-in-relapsedrefractory-diffuse-large-b-cell-lymphoma-rr-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-epcoritamab-r-chop-in-patients-with-newly-diagnosed-dlbcl-and-high-ipi-scores-3-5 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-treatments-with-food-restrictions-on-adherence-and-quality-of-life-aspects-among-cml-patie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-germline-and-somatic-mutation-profile-of-diamond-blackfan-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-recovery-and-immunologic-remodeling-after-cd19-directed-chimeric-antigen-receptor-t-cell-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-inaticabtagene-autoleucel-in-adult-b-cell-acute-lymphoblastic-leukemia-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-following-pemivibart-for-covid-19-pre-exposure-prophylaxis-in-immunocompromised 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pomalidomide-salvage-in-t-cell-engager-monotherapy-failures-real-world-experience-with-talquetamab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-recipient-sociodemographic-factors-on-allogeneic-transplant-conditioning-intensity-and-sur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-combined-with-venetoclax-for-pre-emptive-treatment-of-amlmds-after-allogeneic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-spontaneous-hlh-mouse-model-by-engrafting-human-hscs-into-b-ndg-mgmt3-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preservation-of-gonadal-function-following-chemotherapy-protocols-with-acvd-and-acvd-bv-in-adults-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-determinants-of-hepatosplenic-t-cell-lymphoma-hstcl-analysis-of-an-updated-real-world-po 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-characterization-of-platelets-in-immune-thrombocytopenia-indicates-sustained-activati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decitabine-enhances-the-cytotoxic-effect-of-ruxolitinib-in-myeloproliferative-neoplasms-by-targeting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mga-loss-promotes-mitochondrial-structure-changes-and-redox-adaptation-in-richters-transformation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fludarabine-cyclophosphamide-and-melphalan-fcm-preconditioning-in-haploidentical-hematopoietic-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-adherence-to-oral-cll-therapies-in-community-oncology-centers-key-findings-from-a-qualit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-presence-of-sh2b3-mutations-identifies-a-distinct-subtype-of-myelodysplastic-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-activity-and-immune-correlates-of-glofitamab-combined-with-tislelizumab-in-relapsedrefract 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-development-of-an-optimized-manufacturing-crispr-edited-fully-non-viral-1xx-enhanced-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/motixafortide-g-csf-hematopoietic-stem-cell-mobilization-in-patients-with-multiple-myeloma-followi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-genomic-landscape-amp-response-dynamics-of-hiv-associated-lymphomas-identified-by-integra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unveiling-prognostic-subtypes-in-myelofibrosis-through-routine-blood-counts-a-population-based-anal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reviewing-management-of-venous-thromboembolism-in-elderly-lymphoma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zfp36l2-as-a-promising-therapeutic-target-in-acute-graft-versus-host-disease-evidence-from-murine-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cyclin-d1-beyond-the-cell-cycle-a-new-role-in-t1114-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-i-open-label-study-of-ctd402-a-universal-cd7-targeting-car-t-cell-therapy-in-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transgenic-expression-of-enhanced-ascas12a-in-mice-enables-in-vivo-multiplex-genetic-editing-and-dev 2026-08-17 monthly 0.7 https://rjrindex.com/articles/test-characteristics-of-end-of-treatment-pet-scans-in-diffuse-large-b-cell-lymphoma-in-a-population 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-patients-with-hairy-cell-leukemia-treated-with-first-line-cladribine-in-britis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-health-literacy-among-patients-with-thalassemia-results-from-a-global-patient-survey 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blood-board-a-virtual-forum-for-classical-hematology-education-and-care-improvement 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myelodysplasticmyeloproliferative-overlap-neoplasms-clinicopathological-features-treatment-strate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/paroxysmal-cold-hemoglobinuria-associated-with-monoclonal-b-cell-lymphocytosis-in-an-elderly-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-single-institution-retrospective-analysis-of-allo-hsct-for-relapsed-and-refractory-aggressive-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-arm-meta-analysis-of-melflufen-based-regimens-in-relapsedrefractory-multiple-myeloma-effica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematopoietic-jak2v617f-mutation-increases-susceptibility-to-atrial-fibrillation-via-nlrp3-inflammas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unraveling-the-mysteries-of-platelet-fatigue-in-cold-storage-calcium-release-dynamics-and-energy-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protein-levels-of-isocitrate-dehydrogenase-1-and-2-are-prognostic-and-independent-of-mutation-status 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idh2-r172-mutation-is-associated-with-improved-survival-in-idh-mutated-amlmds-patients-undergoing-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/runx1-mutations-define-a-high-risk-biological-subset-of-chronic-myelomonocytic-leukemia-and-cooperat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-and-integrated-analysis-of-oral-and-stool-microbiome-in-allogeneic-hematopoietic-cell-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/abatacept-in-combination-with-post-transplant-cyclophosphamide-and-tacrolimus-may-improve-survival-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/upfront-continuous-btk-inhibitor-btki-versus-time-limited-venetoclax-btki-combinations-in-cll-acro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/foreign-antigen-delivered-to-cll-b-cells-via-membrane-igd-leads-to-a-distinct-antigen-processing-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-genomic-analysis-for-the-early-identification-of-complement-abnormalities-in-adults-with-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-ipss-m-a-comorbidity-integrated-model-for-improved-clinical-risk-stratification-in-myelody 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dex-and-il-7-enhance-persistence-of-car-t-cells-to-promote-long-term-remission-in-mouse-models-of-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-in-t-follicular-helper-cell-lymphoma-a-prognostic-biomarker-and-early-event-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-risk-stratification-in-patients-with-direct-antixa-inhibitors-related-bleedi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcome-of-bridging-therapy-in-chimeric-antigen-receptor-t-cell-treatment-for-relapsedrefractory-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-predictors-of-inpatient-mortality-in-patients-with-aplastic-anemia-a-7-year-national-inp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/translational-potential-in-research-focused-on-hematological-neoplastic-diseases-results-of-automa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/performance-of-different-large-language-models-llms-as-decision-support-tools-across-various-hemat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mim8-improves-the-in-vivo-hemostasis-of-select-hemophilia-b-causing-factor-ix-variants 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-cohort-analysis-of-treatment-patterns-and-bleeding-outcomes-in-the-korean-bleeding-dis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-from-haven-1-4-to-further-contextualize-injection-site-reactions-among-people-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-normalization-of-platelet-counts-in-patients-with-refractory-thrombocytopenia-associated-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiovascular-disease-risk-scores-as-predictors-of-cardiovascular-disease-and-heart-failure-in-allo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-identifies-a-klf5-neutrophil-plasma-cell-axis-driving-immune-suppression-in-poe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-dissociated-and-spatial-single-cell-profiling-reveals-that-hdac-inhibition-restores-anti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-in-patients-with-sh2b3-mutated-erythrocytosis-a-retrospective 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-influencing-relapse-and-survival-of-childhood-acute-lymphoblastic-leukemia-with-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-of-diffuse-large-b-cell-lymphoma-racial-and-socioeconomic-disparities-in-a-natio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-platelet-variability-index-tool-to-determine-the-likelihood-of-immune-thrombocytopenia-itp-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-variants-in-congenital-fibrinogen-deficiency-by-next-generation-sequencing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aiming-at-immune-fitness-in-cancer-longitudinal-functional-profiling-to-predict-clinical-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golseek-1-a-phase-3-double-blind-randomized-study-of-golcadomide-golca-a-potential-first-in-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/s100a8a9-drives-t-cell-exhaustion-and-compromises-the-therapeutic-efficacy-of-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effects-of-curative-and-disease-modifying-therapies-on-ineffective-erythropoi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-mechanism-of-btk-degrader-nx-5948-in-secondary-hemophagocytic-lymphohistiocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hematopoietic-lineage-specific-deletion-of-cyb5r3-on-steady-state-and-stress-erythropoiesi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aplastic-anemia-mortality-in-the-united-states-1999-2023-trends-disparities-and-public-health-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-venous-and-arterial-thromboembolic-events-following-car-t-therapy-in-relapsed-or-refractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-dual-primary-t-cell-and-b-cell-lymphoid-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/smartphone-app-for-noninvasive-at-home-pediatric-hemoglobin-monitoring-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-enables-automated-quantification-of-hematopoietic-stem-and-progenitor-cells-hspcs-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-trajectory-and-prognosis-of-measurable-residual-disease-mrd-in-t1114-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-bispecific-blind-spot-uncovering-real-world-inequities-in-diffuse-large-b-cell-lymphoma-follic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-cardiac-related-deaths-among-patients-aged-65-years-with-b-cell-malignancies-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/target-antigen-density-may-impact-clinical-response-in-patients-with-relapsedrefractory-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epithelial-growth-factor-like-7-egfl7-regulates-hematopoiesis-stem-cell-hsc-activation-via-ap-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lower-neutrophil-counts-after-hematopoietic-stem-cell-transplant-for-sickle-cell-disease-patients-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phf19-inhibition-increases-imids-sensitivity-by-epigenetically-regulating-irf4-and-myc-in-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-associated-with-conditioning-regimens-in-patients-with-primary-central-nervous-sys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-car-t-pulmonary-function-test-and-respiratory-comorbidities-have-limited-predictive-value-for-su 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-updated-uk-real-world-analysis-of-factors-affecting-outcome-following-brexucabtagene-autoleucel-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-characteristics-and-outcomes-of-acute-lymphoblastic-leukemia-all-in-adults-with-central-ne 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-for-hemophilia-a-since-the-launch-of-emicizumab-in-the-us 2026-08-17 monthly 0.7 https://rjrindex.com/articles/abc-highly-active-and-entirely-calcineurin-and-m-tor-inhibitor-free-gvhd-prevention-regimen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oxidative-stress-and-hemoglobin-c-denaturation-drive-hemoglobin-sc-pathophysiology-and-can-be-amelio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-inflammatory-drug-pegtarazimod-rls-0071-demonstrates-clinical-improvement-in-lower-gastrointe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-i-study-of-jak-inhibitor-ruxolitinib-with-and-without-ctla-4-ig-abatacept-for-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-circulating-activated-foxp3-regulatory-t-cell-subset-in-patients-with-advanced-chronic-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanism-of-acquired-resistance-to-histone-deacetylase-inhibitor-romidepsin-in-myeloid-leukemia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacological-targeting-of-ctps1-elicits-macrophage-mediated-anti-leukemia-immunity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-chromatin-remodeling-protein-arid1a-is-required-for-mll-af9-leukemogenesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-archetypes-of-clonal-dynamics-underlie-response-and-resistance-to-diverse-cll-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-burdens-associated-with-receiving-car-t-cell-therapy-a-qualitative-study-of-car-t-patients-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sight-sickle-cell-identification-from-general-hematological-testing-a-machine-learning-approach-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-prognostic-modeling-of-venetoclax-enhanced-intensive-chemotherapy-in-fit-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd3cell-dose-is-an-independent-risk-factor-for-grade-ii-iv-agvhd-following-cord-blood-transplantati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-stem-cell-collection-for-patients-with-multiple-myeloma-undergoing-autologous-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-immune-profiling-in-newly-diagnosed-multiple-myeloma-associations-with-mrd-status 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-ameliorates-refractory-chronic-graft-versus-host-disease-through-sh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/more-than-a-decade-without-treatment-time-to-first-treatment-in-cll-in-a-chilean-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-challenges-in-adult-hemophagocytic-lymphohistiocytosis-a-case-series 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sinusoidal-endothelial-cell-derived-fgf23-modulates-hematopoiesis-in-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-drug-response-profiling-predicts-clinical-outcomes-and-shows-utility-for-treatment-strati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-chronic-kidney-disease-on-outcomes-in-patients-admitted-with-acute-promyelocytic-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-medicaid-expansion-on-survival-outcomes-among-individuals-with-chronic-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rxr-agonist-irx4204-enhances-bcma-car-t-cell-efficacy-by-suppressing-ferroptosis-via-chac1-downregul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomics-reveals-proliferative-immune-evasive-and-bone-marrow-independent-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genotype-guided-comparison-of-ven-hma-versus-intensive-chemotherapy-in-newly-diagnosed-intermediate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-new-deferasirox-derived-compounds-for-the-treatment-of-iron-overload 2026-08-17 monthly 0.7 https://rjrindex.com/articles/study-of-video-electroencephalogram-features-for-predicting-28-day-survival-in-critical-hematologic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-with-intermediate-intensity-pediatric-inspired-regimen-and-allo-hsct-in-adults-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-car-t-idecabtagene-vicleucel-in-advanced-myeloma-plus-iberdomide-or-usual-monit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/duffy-null-phenotyping-reduces-unnecessary-workup-in-asymptomatic-neutropenia-a-quality-initiative 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiple-hla-loss-clones-are-required-for-hematologic-regeneration-in-immune-aplastic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-bortezomib-thalidomide-and-dexamethasone-improves-renal-outcomes-in-multiple-myeloma-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-impact-of-somatic-mutations-in-patients-with-aplastic-anemia-aa-undergoing-allogene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/castleman-disease-as-a-spectrum-characterization-of-novel-subtypes-using-data-from-the-spanish-gelt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effects-of-golidocitinib-and-gecacitinib-in-mouse-models-of-primary-and-secondary-hemophagocytic-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fraternal-but-not-identical-twins-hlh-and-icans-look-a-lot-alike 2026-08-17 monthly 0.7 https://rjrindex.com/articles/navigating-hematology-and-medical-oncology-fellowship-websites-a-comprehensive-review-and-implicati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/septin6-mutations-in-pediatric-myelodysplastic-syndrome-disrupt-nuclear-actin-organization 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd43-functions-as-a-cd47-independent-dont-eat-me-signal-and-novel-immune-checkpoint-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-targeting-of-focal-adhesion-kinase-fak-modulates-oncogenic-and-immune-pathways-in-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/title-hacs1-is-a-myeloma-immunosuppressor-driving-pro-tumorigenic-myelopoiesis-and-myeloid-cell-dif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-immunophenotyping-reveals-mutation-specific-immune-alterations-in-severe-congenital-neut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-treatment-initiation-and-early-outcomes-among-patients-with-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-high-dose-methotrexate-treatment-regimens-to-improve-exposure-and-mitigate-toxicity-in-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-patients-with-indolent-acute-myeloid-leukemia-long-term-survivors-after-best-supportive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toxicity-efficacy-and-clinical-management-of-bispecific-antibodies-in-routine-clinical-practice-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-serum-tie-2-levels-in-newly-diagnosed-and-untreated-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-of-cerebral-venous-sinus-thrombosis-in-hematologic-malignancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-bispecific-antibodies-into-community-myeloma-care-challenges-insights-and-educational 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maternal-morbidity-and-predictors-of-adverse-outcomes-in-pregnant-women-with-sickle-cell-disease-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-the-unknown-leveraging-machine-learning-to-predict-adverse-outcomes-in-pregnant-women-with-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extranodal-involvement-of-the-gastrointestinal-tract-in-post-transplant-lymphoproliferative-disorder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-and-tolerability-of-a-cd4-re-directed-chimeric-antigen-receptor-t-cell-therapy-cd4car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/developing-v-thalassemia-mouse-model-by-deleting-hbb-genes-for-therapeutic-evaluation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revisiting-morbidities-and-predictors-in-transfusion-dependent-thalassemia-a-cohort-study-over-10 2026-08-17 monthly 0.7 https://rjrindex.com/articles/congenital-dyserythropoietic-anemia-type-i-updated-report-from-the-congenital-dyserythropoietic-ane 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ap-3-targets-the-mrgbptip60myc-axis-to-exert-potent-anti-t-all-effects-in-a-notch1-independent-man 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterisation-of-the-megakaryocyte-proteome-in-patients-with-philadelphia-negative-myeloprolifera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/activating-stim1-mutations-drive-the-development-of-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oxygen-dependency-as-a-critical-regulatory-axis-affecting-hematopoietic-stem-and-progenitor-cell-fun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-management-of-congenital-thrombotic-thrombocytopenic-purpura-in-latin-america-expert-conse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pola-based-therapy-in-molecularly-defined-high-risk-dlbcl-a-retrospective-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intelligent-bispecific-bcma-cd24-car-t-cells-for-precision-navigation-and-elimination-of-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-external-validation-of-an-individuals-machine-learning-clinical-decision-support-prediction 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interpretable-deep-learning-predicts-polycythemia-vera-and-identifies-novel-genomic-associations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stepwise-leukemogenesis-and-therapeutic-targets-revealed-in-b-cell-acute-lymphoblastic-leukemia-driv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/split-dose-r-chop-mitigates-toxicity-while-preserving-dose-intensity-and-response-in-frail-elderly-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcoritamab-epcor-monotherapy-offers-long-term-disease-control-in-large-b-cell-lymphoma-lbcl-nh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/human-hepatocyte-engraftment-in-f8ko-tk-nog-mice-creating-a-novel-hemophilia-a-mouse-model-with-fun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-combined-with-dexamethasone-is-a-promising-prophylaxis-method-for-differentiation-syndro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-prophylaxis-in-people-with-non-severe-hemophilia-in-the-united-states-insights-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-immune-profiling-reveals-t-cell-exhaustion-in-ebv-monomorphic-ptld-vs-immunocompetent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-unified-spatial-amp-molecular-atlas-of-anatomically-restricted-large-b-cell-lymphomas-defines-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ev-mirnas-predict-outcomes-in-pediatric-aml-a-pilot-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-activating-antibodies-to-the-chemokine-platelet-factor-4-in-cerebral-malaria-differ-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oncodif-an-auditable-ai-framework-for-automated-genomic-curation-and-natural-language-clinical-quer 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-immune-reconstitution-dynamics-in-refractory-t-all-treated-with-cd7-car-t-cells-bridgin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-immune-checkpoint-landscapes-in-pcnsl-and-scnsl-revealed-by-single-nucleus-profiling 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mapping-out-the-impact-of-map-kinase-in-primary-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-ngs-detection-of-tp53-mutations-in-chronic-phase-primary-myelofibrosis-comparative-analyse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ponatinib-as-a-consolidation-strategy-for-a-second-attempt-at-tki-discontinuation-in-chronic-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-modified-delphi-consensus-on-the-management-of-patients-with-relapsed-or-refractory-flt3-mutated-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-temporal-trends-and-demographic-disparities-in-primary-immunodeficiency-related-mortality-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-parsimonious-clinically-interpretable-logistic-model-for-anemia-in-plwha-feature-selection-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differential-impact-of-clonal-hematopoietic-mutations-on-10-year-atherosclerotic-cardiovascular-dise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-ctcs-combined-with-frailty-index-offer-an-improved-stratification-system-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liposomal-mitoxantrone-versus-chidamide-in-relapsedrefractory-peripheral-t-cell-lymphoma-final-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combining-mertk-inhibitor-mrx-2843-with-venetoclax-and-5-azacitidine-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tali-cel-is-a-safe-and-effective-therapy-in-patients-with-relapsedrefractory-b-cell-non-hodgkin-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-adolescent-and-young-adult-aya-age-acuity-of-illness-at-diagnosis-and-clinic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/progression-of-disease-within-36-months-pod36-of-starting-first-line-targeted-therapy-independentl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mrd-guided-venetoclax-obinutuzumab-in-cll-final-analysis-of-the-cll2-bag-trial-of-the-gcllsg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiomic-correlates-of-ex-vivo-acd19-chimeric-antigen-receptor-t-cell-cart-cytotoxicity-in-veneto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/demographic-trends-in-acute-myeloid-leukemia-related-mortality-in-the-united-states-a-25-year-natio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-depth-quantitative-characterization-of-important-regulators-and-predictive-biomarkers-for-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/live-imaging-of-human-xenogeneic-cart-cells-in-a-clinical-trial-of-companion-dogs-with-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diffuse-large-b-cell-lymphoma-in-brazil-understanding-the-patient-journey-to-improve-healthcare-ass 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-cardiac-outcomes-after-car-t-in-patients-with-hematologic-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-newly-diagnosed-non-germinal-center-large-b-cell-lymphoma-patients-treated-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-lymphoproliferative-disorders-in-adult-transplant-recipients-preliminary-results-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/space-associated-stem-cell-hallmarks-of-aging-sasha-in-astronauts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chimeric-antigen-receptor-car-t-cell-persistence-at-month-3-predicts-clinical-outcomes-in-adult-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lenalidomide-len-and-anti-cd38-monoclonal-antibodies-mabs-utilization-in-patients-with-newly-dia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cyclophosphamide-versus-methotrexate-for-treating-large-granular-lymphocyte-leukemia-real-world-dat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloid-derived-suppressor-cells-are-expanded-in-the-antiphospholipid-antibody-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognosis-of-therapy-related-hematological-neoplasms-a-single-center-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-silico-design-of-degron-tags-for-precise-modulation-of-car-t-cell-activity-using-clinically-utili 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-kinetics-of-circulating-multiple-myeloma-cells-cmmcs-predict-resistance-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disruption-of-nad-and-gshgpx4-axis-via-nampt-inhibition-by-elaiophylin-sensitizes-aml-to-ferroptos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-romiplostim-n01-in-cancer-treatment-induced-thrombocytopenia-results-from-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-economic-burden-of-cytokine-release-syndrome-in-a-nationally-representative-cohort-of-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlates-of-response-to-combined-checkpoint-and-btk-inhibition-for-treatment-of-richter-transforma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/three-year-efficacy-and-longitudinal-safety-of-lisocabtagene-maraleucel-liso-cel-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatiotemporal-and-genetic-tracking-of-long-term-persisting-car-t-cells-following-ciltacabtagene-aut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gvhd-intel-10-a-scalable-hla-enhanced-machine-learning-model-for-predicting-acute-and-chronic-gvh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcma-targeted-car-t-cells-for-multi-refractory-primary-immune-thrombocytopenia-a-pilot-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adverse-event-profiles-of-acalabrutinib-and-zanubrutinib-in-chronic-lymphocytic-leukemia-a-real-wor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/xeroderma-pigmentosum-as-a-germline-predisposition-syndrome-for-haematological-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-of-first-line-luspatercept-in-patients-with-myelodysplast 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monoclonal-gammopathy-related-coagulopathies-a-systematic-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-antecedent-clonal-hematopoiesis-ch-mutations-in-lymphoid-and-plasma-cell-neopl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/five-year-interim-analysis-of-multi-institutional-collaborative-study-for-estimating-the-persistence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd90-targeted-multiplex-virus-like-particles-mvps-for-concomitant-in-vivo-gene-editing-transducti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/indirect-comparison-of-efficacy-of-zanubrutinib-vs-ibrutinib-for-the-treatment-of-relapsedrefractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-tolerability-and-efficacy-of-mesutoclax-to-treat-patients-with-myeloid-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-dose-escalation-and-safety-study-of-cid-103-followed-by-a-randomized-open-label-parallel-arm-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/examining-tp53-mutated-plasma-cell-disorders-across-the-disease-spectrum-using-broad-next-generation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-venetoclax-and-hypomethylating-agents-hma-in-blastic-plasmacytoid-dendritic-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-dna-methylation-based-classification-of-hematological-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-safety-of-oral-administration-of-hbi-002-carbon-monoxide-drug-product-in-healthy-subjects-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelet-transfusion-is-associated-with-reduced-thrombosis-yet-elevated-mortality-in-consumptive-thr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-phase-1-study-of-incb160058-a-first-in-class-jak2v617f-mutant-selective-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-duffy-genotype-on-progression-free-survival-pfs-with-lenalidomide-bortezomib-and-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hallmarks-of-allogeneic-hematopoietic-cell-transplant-success-a-study-on-immune-signatures-and-pred 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dose-and-btk-occupancy-relationship-in-the-prospective-phase-2-tailor-study-exploratory-end-point-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-prognostic-mutations-on-outcomes-with-fixed-duration-acalabrutinib-venetoclax-combinations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-study-of-ct0596-an-allogeneic-car-t-cell-therapy-targeting-bcma-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unravelling-molecular-determinants-of-ruxolitinib-treatment-response-in-myelofibrosis-using-single-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-dual-targeting-bcma-and-cd19-fastcar-t-gc012fazd0120-as-first-line-therapy-for-newly-diagnosed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hetrombopag-for-the-treatment-of-chemotherapy-induced-thrombocytopenia-in-advanced-solid-tumors-a-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hem-ismart-an-international-proof-of-concept-therapeutic-stratification-trial-of-molecular-anomalie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revumenib-for-patients-with-relapsed-or-refractory-rr-kmt2ar-acute-leukemia-outcomes-by-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-generation-of-anti-cd19-car-t-cells-for-the-treatment-of-b-cell-mediated-autoimmune-diseases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crenolanib-plus-salvage-chemotherapy-improves-outcomes-in-flt3-mutant-and-npm1-co-mutated-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/emapalumab-induces-rapid-durable-responses-and-reliable-bridging-to-curative-hsct-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-from-the-first-clinical-trial-of-the-selective-glyt1-inhibitor-bitopertin-for-steroid-refrac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-long-term-antigen-spreading-by-novel-cancer-vaccine-with-hyaluronic-acid-nanogel-accelerate-the-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/uric-acid-a-potent-antioxidant-with-protective-and-toxic-affects-on-renal-function 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-first-line-selinexor-plus-r-chop-in-tp53-mutated-diffuse-large-b-cell-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-demographics-of-autoimmune-hemolytic-anemia-in-the-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-isa-vrd-in-elderly-patients-with-or-without-frailty-criteria-pooled-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-new-prognostic-index-clipi-stratifies-risk-in-advanced-cutaneous-lymphomas-associations-with-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-antithrombin-sirna-fitusiran-as-prophylaxis-in-haemophilia-a-and-b-a-sys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploiting-hla-e-restricted-t-cell-receptors-to-develop-universal-cellular-therapies-for-virus-assoc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-receptors-targeting-mutant-npm1-for-adoptive-cell-therapy-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dosing-patterns-of-ponatinib-in-patients-with-chronic-phase-chronic-myeloid-leukemia-and-effect-on-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-dose-optimization-phase-1b2-study-evaluating-mipletamig-formerly-apvo436-a-novel-bispecific-cd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/altered-osteoblast-populations-dynamics-underlie-myeloma-progression-from-precursors-diseases-in-bon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revisiting-erythroid-response-in-the-phase-3-believe-trial-of-luspatercept-in-patients-with-transfus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-update-safety-and-efficacy-of-gprc5d-targeting-car-t-cell-therapy-in-relapsedrefractory-multipl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-genotoxic-conditioning-to-increase-donor-chimerism-levels-in-a-mismatched-murine-transplant-mode 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-and-ppm1d-mutations-in-aml-distinct-frequencies-shared-pathway-and-adverse-prognostic-trends 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-sepsis-related-mortality-among-patients-with-acute-myeloid-leukemia-a-24-year-nationwide 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-transplant-bone-marrow-cellularity-and-fibrosis-on-post-transplant-outcomes-in-sickle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-barriers-to-clinical-trial-enrollment-for-children-with-relapsed-or-refractory-hematolog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-subtypes-and-bh3-mimetic-synergy-with-anti-leukemia-agents-in-t-cell-acute-lymphoblastic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-exploratory-analysis-of-health-related-quality-of-life-measures-with-belantamab-mafodotin-in-comb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/usp28-inhibition-upregulates-cd20-via-c-myc-suppression-and-synergizes-with-anti-cd20-immunotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-elranatamab-in-relapsedrefreactor-multiple-myeloma-a-single-center-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-i-monotherapy-study-assessing-the-safety-and-efficacy-of-gr1803-a-bcmacd3-bispecific-antib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-leukemic-efficacy-of-a-novel-inhibitor-for-kmt2a-rflt3-driven-aml-via-multi-kinase-targeting-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-pathways-of-antibody-dependent-phagocytosis-distinct-kinetics-finite-capacities-and-therapeu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/visualizing-systemic-light-chain-amyloidosis-with-18f-flutemetamol-petct-correlation-with-biomarke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-the-impact-of-chronic-red-blood-cell-transfusion-on-day-to-day-functioning-in-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/point-of-care-musculoskeletal-ultrasound-in-hemophilic-arthropathy-evidence-synthesis-clinical-imp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-second-line-therapies-for-chronic-immune-thrombocytopenia-a-network-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-inactivation-of-duodenal-ferroportin-by-hepcidin-drives-iron-dependent-degradation-of-dmt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-risk-of-thrombosis-in-adults-with-primary-immune-thrombocytopenia-treated-with-eltrombop 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-mineral-density-findings-in-patients-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-rearrangement-partner-and-the-presence-of-myc-mutations-determines-outcome-of-patients-with-myc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dual-roles-of-proton-pump-inhibitors-in-estrogen-induced-venous-thromboembolism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-g-csf-in-aml-patients-with-febrile-neutropenia-friend-or-foe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/end-of-study-analysis-of-the-hope-b-trial-confirms-the-durable-efficacy-and-safety-of-etranacogene-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orelabrutinib-combined-with-short-course-bendamustine-rituximab-br-for-first-line-treatment-of-chr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mutations-landscape-of-relapsed-refractory-multiple-myeloma-patients-prior-to-anti-bcma-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iberdomide-plus-daratumumab-and-dexamethasone-iberdd-in-patients-with-newly-diagnosed-multiple-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modified-release-formulation-of-decitabine-and-tetrahydrouridine-combination-not-only-increases-expo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/who-needs-second-line-therapy-predictors-of-sustained-response-in-autoimmune-hemolytic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-commercially-available-chimeric-antigen-receptor-car-detection-reagents-for-monitori 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ravulizumab-demonstrates-real-world-effectiveness-in-patients-with-paroxysmal-nocturnal-hemoglobinur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-in-oncology-a-cross-sectional-analysis-of-chatgpt-and-openevidence-performa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-mass-spectrometry-approach-for-blood-group-antigen-typing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-drives-t-cell-dysregulation-and-immune-remodeling-revealed-by-gwas-based-mendel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pomalidomide-downregulates-fiz1-to-induce-fetal-hemoglobin-in-adult-erythroid-progenitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-multiple-sclerosis-above-age-60-have-neurological-responses-to-autologous-hematopoieti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maintenance-therapy-following-chimeric-antigen-receptor-t-cell-therapy-in-relapsed-and-refractory-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overcoming-asciminib-resistance-by-targeting-compound-bcrabl1-mutations-in-chronic-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/successful-melphalan-flufenamide-melflufen-therapy-in-patients-with-severe-renal-insufficiency 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-analysis-of-newly-diagnosed-systemic-light-chain-amyloidosis-patients-treated-with-daratu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospecitive-multicenter-study-of-chidamide-in-adult-patients-with-refractory-primary-immune-thro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptional-programming-by-gata3-regulates-cd4-t-cell-gm-csf-production-in-the-gastrointestinal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-levetiracetam-prophylaxis-in-blinatumomab-induced-neuro-toxicities-in-acute-lymphoblasti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/donor-and-recipient-age-related-differences-in-immunological-reconstitution-affect-development-of-ch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-aponermin-based-chemotherapy-as-bridging-therapy-before-car-t-cell-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-dysregulated-lipid-metabolism-is-associated-with-cd8-t-cell-senescence-in-hiv-associated-diffus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-induction-minimal-residual-disease-assessment-by-flow-cytometry-and-molecular-biology-enables-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-cardiac-events-associated-with-next-generation-bruton-tyrosine-kinase-btk-inhibitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-achieving-complete-response-in-patients-older-than-65-years-diagnosed-with-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-simulated-exposure-of-inotuzumab-ozogamicin-with-and-without-dose-capping-in-overweigh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/number-of-patients-needed-to-treat-to-prevent-one-atrial-fibrillation-event-with-zanubrutinib-versus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-analysis-reveals-impaired-immune-profiles-in-elderly-aml-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimai-20-functional-precision-platform-for-identifying-effective-immunotherapy-combinations-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-mixed-chimerism-with-undetectable-measurable-residual-disease-in-pediatric-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/resolving-the-debate-a-systematic-review-and-network-meta-analysis-of-hydroxyurea-vs-newer-fda-app 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-malignancies-among-cll-survivors-across-treatment-eras-a-seer-based-study-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/which-inflammation-matters-distinct-risk-signatures-before-car-t-cell-therapy-and-the-role-of-infla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/addition-of-venetoclax-to-hypomethylating-agent-offers-limited-incremental-benefit-for-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-hemophagocytic-lymphohistiocytosis-hlh-in-an-urban-population-demographics-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-outcomes-and-unmet-needs-in-patients-with-ph-all-receiving-tyrosine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cva-with-undetectable-adamts13-without-hemolysis-an-atypical-presentation-of-thrombotic-thrombocyto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-essential-link-between-pyrimidine-synthesis-and-ferroptosis-suppression-in-erythroid-differentiat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cdk6-targeting-reverses-leukemia-in-germline-cebpa-q83x-aml-mouse-model-with-cmp-origin-transformati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-voxelotor-on-the-reduction-in-red-blood-cell-transfusions-in-us-patients-with-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-prospective-phase-ii-study-of-decitabine-priming-combined-with-low-dose-idarubicin-cyta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thyroid-hormones-enhance-the-responsiveness-of-t-cell-lymphomas-to-romidepsin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implementation-challenges-of-the-learner-clinical-trial-in-pregnant-women-with-sickle-cell-disease-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-large-language-models-in-lymphoma-clinical-scenarios-a-comparative-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-dissection-of-car-t-and-blinatumomab-elicited-t-cell-states-uncovers-therapy-specific-fu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-cytokine-profiles-with-clinical-and-molecular-biomarkers-to-predict-molecular-relapse-af 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparing-the-safety-of-direct-oral-anticoagulants-vs-low-molecular-weight-heparin-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-atra-based-maintenance-therapy-and-prognostic-markers-of-relapse-in-acute-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-future-projections-of-sepsis-mortality-in-leukemia-a-nationwide-analysis-of-dem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multivariable-adjusted-validation-of-iwg23-defined-peripheral-blood-complete-remission-pb-cr-and-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-fixed-duration-chemo-sparing-approach-in-cll-8-year-results-of-the-phase-2-icll-07-filo-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/jagged-1-damage-resistant-myeloid-progenitors-initiate-the-recovery-of-the-bone-marrow-endothelial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-posaconazole-vs-voriconazoleisavuconazole-for-antifungal-prophylaxis-in-ne 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-newly-diagnosed-acute-myeloid-leukemia-with-flt3-tkd-a-multicenter-retrospe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orelabrutinib-plus-bendamustine-rituximab-obr-versus-bendamustine-rituximab-br-in-transplant-ine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inpatient-systemic-therapy-for-cllsll-in-the-united-states-2016-2022-trends-disparities-and-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-with-icos-costimulation-lacks-therapeutic-efficacy-in-patient-due-to-strong-trogocytosis-and-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-hematologic-profiles-in-mesoamerican-versus-classical-chronic-kidney-disease-a-focus-on-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pola-r-edch-shows-high-response-rates-in-high-risk-aggressive-b-cell-lymphomas-or-pmbcl-a-phase-2-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-among-patients-treated-with-second-generation-btk-inhibitors-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-polatuzumab-in-combination-with-chemoimmunotherapy-for-richter-transformation-pol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-evolution-in-cml-patients-from-diagnosis-to-tki-failure-an-analysis-of-121-paired-diagnosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/igg2a-formatted-4-1bb-agonism-combined-with-s100a9-inhibition-enhances-t-cell-activation-and-tumor-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-azacitidine-plus-ldac-in-newly-diagnosed-frail-elderly-patients-with-acute-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-function-alterations-in-traf3-drive-btkplcg2-independent-ibrutinib-resistance-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bleeding-disorder-of-unknown-cause-is-there-a-role-for-expanded-platelet-testing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-and-refinement-of-the-new-high-risk-multiple-myeloma-hrmm-criteria-in-relapsed-or-refra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aberrant-clonal-plasma-cells-bypass-the-proteasome-proteostasis-by-endoplasmic-reticulum-associated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-randomized-placebo-controlled-phase-1-study-of-rpt1g-a-novel-hyperbolic-nampt-inhibi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/co-targeting-menin-and-ras-in-kmt2a-rnpm1c-aml-with-activated-rtkrasmapk-signaling 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimal-dosing-of-vobramitamab-duocarmazine-a-cd276-b7-h3-antibody-drug-conjugate-leads-to-durab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extrafollicular-b-cell-expansion-in-covid-19-patients-with-prothrombotic-antibodies-linked-to-inflam 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trans-auricular-vagal-nerve-stimulation-as-an-innovative-approach-to-pain-treatment-in-sickle-cell-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-chimeric-antigen-receptor-t-cell-therapy-in-relapsedrefractory-b-cell-acute-lymphobla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinically-relevant-bleeding-and-heavy-menstrual-bleeding-among-patients-amplt21-years-old-with-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-optimizing-the-serum-ferritin-threshold-for-diagnosis-of-iron-deficiency-a-pre-and-post 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-of-hlh-like-syndromes-across-car-t-cell-products-a-multi-institutional-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-lean-thinking-approach-to-improve-efficiency-in-providing-immune-chemotherapy-injection-in-out-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-anemia-and-chronic-lower-respiratory-diseases-related-mortality-1999-2023-a-cdc-wonder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delays-in-hydroxyurea-initiation-for-patients-with-sickle-cell-disease-in-british-columbia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-canadian-national-needs-assessment-for-an-immunology-curriculum-for-hematology-residents 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-quality-improvement-project-to-improve-the-recognition-and-management-of-iron-delivery-in-the-post 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-antiphospholipid-antibody-positivity-in-a-real-world-laboratory-over-two-decades 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tocilizumab-prophylaxis-in-preventing-cytokine-release-syndrome-and-immune-effector-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-versus-late-onset-hematologic-immune-related-adverse-events-following-immune-checkpoint-inhibi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-anti-cd19cd20-bispecific-car-t-cell-therapy-jwcar201-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biology-of-circulating-tumor-cells-ctcs-in-multiple-myeloma-mm-comparative-transcriptomic-profi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-treatment-of-cns-lymphoma-with-zanubrutinib-and-tislelizumab-a-phase-ibii-inves 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolomics-profiling-and-machine-learning-prediction-of-efficacy-and-prolonged-cytopenia-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-3-and-5-year-outcomes-among-first-line-imatinib-dasatinib-and-nilotinib-in-chronic-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interferon-alfa-treatment-of-early-primary-myelofibrosis-is-associated-with-improved-overall-surviva 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-effects-of-tmprss6-suppression-are-negated-by-iron-overload-in-a-mouse-model-of-beta-tha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-lsd1-inhibitor-bomedemstat-in-participants-with-polycythemia-vera-pv-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-use-and-safety-of-peripheral-intravenous-catheters-piv-vs-central-venous-catheters-cvc-for-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-study-of-single-center-pdt-all-2016-regimen-in-the-treatment-of-kmt2a-rearranged-acute-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/filamin-a-expression-in-acute-myeloid-leukemia-a-multi-omic-analysis-of-prognostic-metabolic-and-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-acute-and-chronic-graft-versus-host-disease-after-unrelated-donor-hematopoie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-3-eslim-01-study-final-analysis-of-efficacy-and-safety-of-long-term-treatment-with-sovlepleni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blinatumomab-improves-erythroid-engraftment-in-major-incompatible-abo-group-hematopoietic-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-zebrafish-model-of-parn-deficiency-identifies-altered-lipid-metabolism-as-a-novel-therapeutic-targ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discontinuation-of-targeted-therapy-in-histiocytic-neoplasms-with-durable-response-a-multicenter-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-classical-hematology-referrals-development-and-early-evaluation-of-an-enhanced-referral 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-at-diagnosis-shapes-stage-and-survival-in-diffuse-large-b-cell-lymphoma-a-22-year-population-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/menstruation-induced-vaso-occlusive-crisis-in-women-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dietary-fiber-intake-improves-survival-in-allogeneic-hct-patients-and-exhibits-synergistic-effects-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-mutations-in-the-dna-methylation-pathway-on-clinical-outcomes-in-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-pregnancies-in-sickle-cell-patients-treated-with-hydroxyurea-findings-from-the-escort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monoclonal-and-polyclonal-circulating-plasma-cells-cpcs-are-linked-to-disease-spread-in-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-bcma-targeted-therapy-on-car-t-expansion-and-host-t-cell-phenotypes-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modeling-discordant-cardiac-and-renal-recovery-trajectories-in-al-amyloidosis-using-interpretable-ma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-characteristics-treatment-patterns-and-outcomes-of-al-amyloidosis-patients-with-high-risk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heart-failure-readmissions-in-patients-with-iron-deficiency-anemia-a-national-readmission-database 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-infection-frequency-and-incident-clonal-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vancomycin-resistant-enterococci-vre-colonization-is-associated-with-worse-outcomes-post-allogenic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dose-adjusted-treatment-with-venetoclax-for-7-days-and-5-azacitidine-or-decitabine-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-early-discharge-clinic-a-safe-and-efficient-model-for-intensive-outpatient-management-of-hemato 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-prognostic-model-for-tp53mutated-myeloid-neoplasms-across-all-myeloid-neoplasm-subtypes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-proteomics-driven-machine-learning-tool-for-distinguishing-et-from-pre-pmf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survey-on-fertility-management-and-outcomes-after-cellular-therapies-on-behalf-of-the-ebmt-cellular 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-fedratinib-and-nivolumab-combination-in-patients-with-myelofibrosis-and-resistan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incb057643-a-bromodomain-and-extra-terminal-protein-inhibitor-in-combination-with-ruxolitinib-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combination-of-cpx-351-and-gemtuzumab-ozogamicin-go-in-relapsedrefractory-rr-acute-myeloid-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-chronic-lymphocytic-leukemia-cll-specific-biomarker-testing-patterns-and-frontline-trea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-incidence-of-complications-related-to-central-venous-line-placement-in-patients-newly-diagnosed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-outcome-with-azacytidine-aza-tocilizumab-tcz-for-reducing-steroid-dependenc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-incidence-and-outcomes-of-transformed-nodular-lymphocyte-predominant-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcome-of-first-time-acute-chest-syndrome-in-patients-with-preexisting-pulmonary-hypert 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outpatient-palliative-care-utilization-in-adults-with-sickle-cell-disease-a-trinetx-based-national 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-hospitalized-patients-with-hyperferritinemia-and-hematologic-malignancies-a-single-cent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/abnormal-metabolic-activation-of-cd8-t-cells-correlates-with-poor-prognosis-in-acute-myeloid-leukem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-premature-mortality-from-hematologic-malignancies-analysis-of-cdc-wonder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-events-as-initial-presentation-of-acute-promyelocytic-leukemia-apl-a-literature-based 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-measurable-residual-disease-mrd-testing-patterns-and-associated-outcomes-in-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-trajectory-informed-mendelian-randomization-demonstrates-consistent-causal-protective-effect-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pacritinib-in-patients-with-high-risk-myelofibrosis-outcomes-from-post-hoc-analyses-of-two-phase-3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maps-r-international-consensus-classification-guided-revision-of-the-mayo-alliance-prognostic-syste 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-risk-of-vascular-events-in-patients-with-myeloproliferative-neoplasms-compared-to-the-dan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-measure-genome-atlas-acute-myeloid-leukemia-at-diagnosis-and-complete-remission 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-life-treatments-and-outcomes-of-older-patients-aged-more-than-60-years-with-flt3-mutated-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/target-dose-delivery-comparison-ibrutinib-venetoclax-vs-acalabrutinib-venetoclax-in-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sepsis-induces-plateletactivating-antipf4-antibodies-with-potential-protective-role-against-second 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-study-of-fluoroquinolone-resistance-colonization-in-patients-undergoing-autologous-hemat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fibrin-clot-shields-drive-clonal-selection-of-cancer-cells-procoagulant-properties-and-proliferativ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-brutons-tyrosine-kinase-inhibitors-in-adults-with-immune-thrombocytopenic-pu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-insights-from-ctdna-dynamics-monitoring-mrd-and-tracking-divergent-progression-modes-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/droplet-digital-pcr-outperforms-conventional-methods-for-early-relapse-prediction-in-amlmds-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multitarget-kinase-inhibitor-olverembatinib-is-active-and-synergizes-with-btk-inhibitor-acalabrutini 2026-08-17 monthly 0.7 https://rjrindex.com/articles/readability-amp-quality-of-large-language-model-responses-in-car-t-patient-education 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-treatment-patterns-in-primary-and-secondary-plasma-cell-leukemia-a-multicente 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-next-generation-flow-ngf-and-next-generation-sequencing-based-clonoseq-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advantages-of-less-frequent-doing-of-bcma-directed-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mecom-gene-network-drives-chemotherapy-resistance-in-high-risk-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-sutimlimab-in-patients-with-cadcas-a-multinational-multi-center-observation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pembro-core-interim-analysis-of-a-phase-ii-pet-adapted-trial-omitting-high-dose-chemotherapy-with-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcore-fl-2-phase-3-trial-of-epcoritamab-with-rituximab-and-lenalidomide-r2-vs-chemoimmunotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/systematic-analysis-of-gene-mutations-in-chinese-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-characteristics-of-myeloid-neoplasms-in-patients-with-multiple-myeloma-treated-with-no 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlation-between-crlf2-expression-by-flow-cytometry-and-fish-in-patients-diagnosed-with-b-cell-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-gcc2005-an-allogeneic-cd5-directed-car-nk-therapy-for-patients-with-relapsedrefr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-potent-and-selective-jak2v617f-inhibitors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inequity-in-travel-burden-among-patients-receiving-bispecific-antibodies-bsabs-for-diffuse-large-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/apixaban-pharmacokinetics-in-newly-diagnosed-multiple-myeloma-patients-treated-in-the-benefit-and-is 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-life-study-of-ivosidenib-in-either-monotherapy-or-combined-with-azacytidine-for-first-line-muta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-treatment-timing-and-access-to-care-in-chronic-lymphoytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disruption-of-il-10-receptor-signaling-promotes-hematopoietic-stem-cell-exhaustion-and-clonal-expans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golidocitinib-based-therapy-in-relapsedrefractory-mycosis-fungoides-and-sezary-syndrome-a-real-wor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrative-single-cell-multi-omic-and-functional-profiling-of-human-bone-marrow-regulatory-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orca-t-improves-chronic-graph-versus-host-disease-free-in-patients-with-a-broad-range-of-demographic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-venetoclax-combined-with-metronomic-low-dose-decitabine-and-interferon-for-preventing-post-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-venetoclax-based-therapy-vs-intensive-chemotherapy-in-older-adults-with-newly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-hetrombopag-a-novel-thrombopoietin-receptor-agonist-in-children-and-adolesc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-specific-ighv-rearrangements-in-younger-untreated-mantle-cell-lymphoma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-is-associated-with-early-onset-clonal-hematopoiesis-involving-dna-damage-respons 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrutinib-in-the-treatment-of-allogeneic-stem-cell-transplant-related-pure-red-cell-aplasia-a-singl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-shortened-venetoclax-course-plus-decitabine-in-newly-diagnosed-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/does-stringent-cytoreduction-improve-survival-in-myeloproliferative-chronic-myelomonocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-monotherapy-versus-active-monitoring-in-patients-with-high-risk-smoldering-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-and-decitabine-in-myeloproliferative-neoplasm-blast-phase-mpn-bp-results-of-enable-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-in-relapsedrefractory-rr-mantle-cell-lymphoma-mcl-final-update-from-the-phase-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-for-newly-diagnosed-chronic-myeloid-leukemia-results-from-a-phase-ii-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gh9d2-t-cell-gh9d2tc-activation-with-ict01-and-azacitidine-venetoclax-aza-ven-induces-high-rates-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/response-adapted-phase-2-study-of-acalabrutinib-window-prior-to-frontline-chemotherapy-in-untreated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rusfertide-or-placebo-plus-current-standard-of-care-therapy-for-polycythemia-vera-durability-of-res 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-2nd-line-treatment-in-cll-after-venetoclax-based-1st-line-treatment-results-from-the-ga 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-peak-car-t-expansion-is-associated-with-delayed-neurotoxicity-following-ciltacabtagene-autoleu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hemoglobin-improvement-with-momelotinib-on-survival-in-patients-with-myelofibrosis-and-ane 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baffr-car-t-cells-pmb-ct01-show-promising-safety-and-anti-leukemia-efficacy-in-relapsedrefractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-pola-r-chp-versus-r-chop-in-patients-with-diffuse-large-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tazemetostat-in-relapsedrefractory-follicular-lymphoma-and-dlbcl-a-systematic-review-of-clinical-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-results-of-the-bruton-tyrosine-kinase-degrader-bgb-16673-in-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pomalidomide-promotes-activation-induced-cell-death-of-pre-activated-memory-bcma-car-t-cells-in-a-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/qls4131-a-next-generation-gprc5dbcmacd3-trispecific-t-cell-engager-in-patients-with-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selinexor-with-alternating-bortezomib-or-lenalidomide-plus-dexamethasone-in-transplant-ineligible-ne 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adult-acute-myeloid-leukemia-with-nup98-rearrangement-benefits-from-targeted-therapy-and-bone-marrow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/limited-stage-mantle-cell-lymphoma-real-world-outcomes-according-to-nodal-vs-extranodal-presentati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-survival-outcomes-in-angioimmunoblastic-t-cell-lymphoma-linked-to-care-at-academic-cancer-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-adult-patients-diagnosed-with-acute-lymphoblastic-leukemia-in-the-us-between-20 2026-08-17 monthly 0.7 https://rjrindex.com/articles/steroid-toxicity-in-newly-diagnosed-patients-with-multiple-myeloma-treated-with-a-limited-dexamethas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toxicity-of-reduced-dose-versus-standard-dose-pegaspargase-in-adolescents-and-young-adults-with-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-promising-results-in-younger-adult-patients-amplt65-yrs-with-newly-diagnosed-phbcrabl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-anti-cd19-chimeric-antigen-receptor-car-t-cell-therapy-in-relapsed-or-refra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ethnic-racial-and-geographic-disparities-in-idiopathic-thrombocytopenic-purpura-related-mortality 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-prophylactic-intrathecal-chemotherapy-to-prevent-high-grade-immune-effector-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-cardiovascular-outcomes-in-patients-with-lymphoma-who-had-early-post-car-t-cardiovascular 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-treatment-regimens-and-related-health-resource-use-in-managing-patients-with-waiha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-health-care-resource-utilization-clinical-effectiveness-and-safety-of-lis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/loss-of-the-y-chromosome-defines-a-biologically-distinct-subtype-of-acute-myeloid-leukemia-aml-as 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-coagulation-potential-of-concomitant-factor-viii-administration-in-patients-with-haemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/petct-parameters-as-predictors-of-early-progression-risk-in-newly-diagnosed-multiple-myeloma-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/journey-of-relapsed-or-refractory-multiple-myeloma-rrmm-after-quadruple-class-exposure-qcex-poo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-ao2-prbcthal-trial-on-the-use-of-hemanext-one-for-blood-transfusion-support-transfusion-depen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-ischemic-heart-disease-and-anemia-related-mortality-in-adults-aged-65-ye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-the-aryl-hydrocarbon-receptor-eliminates-leukemia-stem-cells-in-murine-models-of-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevation-of-liver-health-biomarkers-before-and-after-etranacogene-dezaparvovec-gene-therapy-in-hemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-transfusion-associated-circulatory-overload-after-blood-products-transfusion-in-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-profiling-of-natural-killer-t-cell-lymphoma-reveals-stratified-immune-features-and-thera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vmx-c001-has-no-effect-on-the-anticoagulant-function-of-heparin-in-healthy-subjects 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-absolute-eosinophil-count-and-outcomes-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-reproductive-factors-and-exogenous-hormone-use-with-the-risk-of-multiple-myeloma-in-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tolerability-and-long-term-survival-of-fragile-or-older-patients-with-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combining-next-generation-sequencing-and-optical-genome-mapping-techniques-to-analyze-genomic-abnorm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inositol-hexakisphosphate-kinase-1-ip6k1-driven-tumor-polyphosphate-may-contribute-to-immune-check 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-outcomes-by-age-comorbidity-frailty-and-treatments-prior-to-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/eno1-promotes-acute-myeloid-leukemia-progression-through-scd1-mediated-lipid-metabolism-reprogrammin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liposomal-melatonin-targets-mutant-hematopoiesis-and-bone-marrow-remodeling-in-mpn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-architecture-efficientnetb1-excels-in-accurate-diagnosis-and-prognosis-of-acute-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-car-next-generation-sequencing-informs-patient-outcomes-in-children-and-young-adults-with-b-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibitors-of-rad51-as-potential-novel-therapies-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcma-cart-therapy-in-29-cases-of-relapsed-or-refractory-multiple-myelomaa-retrospective-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-risk-mds-in-the-wke-of-anti-bcma-cart-therapy-in-refractory-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-event-free-survival-in-patients-with-ighv-mutated-high-count-monoclonal-b-cell-lymphocytos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pd-1-expression-on-richter-syndrome-tumor-cells-does-not-provide-a-growth-advantage-in-murine-or-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/continuous-venetoclax-for-relapsed-chronic-lymphocytic-leukemia-cll-characteristics-and-outcomes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-of-patients-with-non-erythrodermic-mycosis-fungoides-with-high-blood 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimating-the-burden-of-undiagnosed-cmml-prevalence-by-phenotype-and-cytopenia-stratification-in-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-rituximab-high-dose-methotrexate-and-thiotepa-r-mt-as-first-line-inductio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impaired-coordination-between-innate-and-adaptive-immunity-in-hematologic-and-solid-cancer-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-presence-clinical-relevance-of-flt3-itd-length-and-location-in-acute-myeloid-leukemia-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-fever-incidence-following-vincristine-administration-in-pediatric-oncolo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-plasma-proteome-of-multiple-myeloma-and-its-precursor-conditions-and-identif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-effect-of-steroid-induced-hyperglycemia-in-early-mortality-during-induction-treatment-of-philade 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-for-newly-diagnosed-bcrabl1-negative-b-cell-acute-lymphoblastic-leukemia-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-multi-institution-experience-of-standard-vs-alternative-dosing-of-inotuzumab-ozogamicin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-results-of-ecog-acrin-ea9152-a-multicenter-study-of-liposomal-vincristine-l-vcr-or-vincr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-hydrochloride-liposome-lipo-mit-combined-with-azacitidine-and-chidamide-can-be-an-ef 2026-08-17 monthly 0.7 https://rjrindex.com/articles/condensed-total-skin-electron-beam-therapy-prior-to-allogeneic-stem-cell-transplantation-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/additional-genetic-targets-are-present-in-the-majority-of-aml-patients-with-npm1-kmt2a-or-nup98-abe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hoxa9mettl3bmi1-axis-is-required-for-promoting-anthracycline-resistance-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/descriptive-analysis-of-igm-monoclonal-gammopathy-of-undetermined-significance-progression-events-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/port-77-is-a-potent-inhibitor-of-abcg2-that-reduces-efflux-of-protoporphyrin-ix-from-erythrocytes-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-multiomics-reveals-candidate-cis-regulatory-elements-in-npm1-mutant-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chemotherapy-free-treatment-for-children-and-adolescents-with-newly-diagnosed-acute-promyelocytic-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-duffy-null-phenotype-on-neutrophil-counts-in-patients-with-hbsc-hbsv-thalassemia-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/resolvins-modulate-haematopoietic-stem-and-progenitor-cell-dysfunction-and-neutrophil-activation-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/regulatory-long-noncoding-rna-of-t-cells-relotlinc00402-impairs-rorght-allogeneic-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-actual-usefulness-of-culturing-apheresis-products-in-hematopoietic-stem-cell-autotransplants 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomics-define-neoplastic-transformation-in-multiple-myeloma-precursor-conditions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/i-feel-like-im-being-recognized-as-being-a-part-of-his-treatment-caregiver-perspectives-of-the-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-microenvironment-overlap-between-vexas-and-myelodysplastic-syndrome-demonstrated-by-targ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-chronotherapeutic-approach-to-vip-receptor-antagonist-ant308-in-anti-tumor-activity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pediatric-idiopathic-multicentric-castleman-disease-is-often-severe-and-responds-to-siltuximab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/automated-grading-of-castleman-disease-histopathology-using-an-attention-based-multiple-instance-lea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autologous-allogeneic-haemopoietic-stem-cell-transplantation-and-cart-cell-therapy-for-tranformed-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-azacitidine-plus-low-dose-dasatinib-maintenance-therapy-for-patients-with-int 2026-08-17 monthly 0.7 https://rjrindex.com/articles/management-of-heparin-induced-thrombocytopenia-in-impella-supported-cardiac-surgery-a-comprehensive 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-11b-open-label-dose-escalation-first-in-human-study-to-evaluate-the-safety-tolerability 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-sorafenib-combined-with-standard-chemotherapy-in-adult-patients-with-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-center-single-arm-study-evaluating-the-safety-and-efficacy-of-golidocitinib-in-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-impacting-treatment-choice-with-a-cd38-antibody-immunomodulator-proteasome-inhibitor-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-monitoring-of-circulating-plasma-cells-in-multiple-myeloma-a-prospective-multicenter-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mass-spectrometry-demonstrates-very-frequent-multi-clonality-in-familial-waldenstrom-macroglobulinem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determining-the-origin-of-tp53-mutations-in-patients-with-mature-b-cell-neoplasms-is-essential-to-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cutaneous-and-peripheral-t-cell-lymphomas-in-the-us-population-a-25-year-national-review-of-epide 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plitidepsin-in-combination-with-dexamethasone-admyre-trial-versus-an-external-control-arm-of-pomal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etiologic-heterogeneity-in-secondary-hemophagocytic-lymphohistiocytosis-a-retrospective-real-world 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haematological-toxicities-with-targeted-drugs-in-tumors-a-systematic-review-and-network-meta-analys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-malignancies-in-patients-with-chronic-lymphocytic-leukemia-treated-with-zanub 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-immunoproteasome-dependent-v-catenin-degradation-as-a-therapeutic-strategy-in-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-hematologic-response-to-daratumumab-without-cardiac-recovery-in-al-amyloidosis-a-persistent-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlation-of-flow-cytometry-ogata-score-with-cytogenetic-abnormalities-in-myelodysplastic-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-repeat-car-t-cell-therapy-a-systematic-review-and-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/malignancy-as-a-secondary-cause-of-hemophagocytic-lymphohistiocytosis-outcomes-and-complications-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-enhancement-of-ghd-t-cell-cytotoxicity-against-tumor-spheroids-through-b7h3-car-and-zoled 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-treatment-patterns-and-overall-survival-for-multiple-myeloma-management-in-taiwan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ofirnoflast-a-novel-inflammasome-inhibitor-rewires-transcriptional-programs-and-shows-clinical-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/melatonin-wnt-and-s1p-signaling-regulate-diurnal-bone-marrow-mesenchymal-stem-cell-metabolism-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-multiple-myeloma-and-diabetes-mellitus-in-the-united-states-a-retrospectiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/concurrent-viral-infection-as-an-adverse-prognostic-factor-in-diffuse-large-b-cell-lymphoma-not-oth 2026-08-17 monthly 0.7